RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Reperfusion Injury |
|
Accession: | DOID:9004009
|
browse the term
|
Definition: | Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the tissue (REPERFUSION), including swelling; HEMORRHAGE; NECROSIS; and damage from FREE RADICALS. The most common instance is MYOCARDIAL REPERFUSION INJURY. |
Synonyms: | exact_synonym: | Ischemia Reperfusion Injury; Ischemia-Reperfusion Injuries; Reperfusion Damage; Reperfusion Damages; Reperfusion Injuries |
| primary_id: | MESH:D015427 |
| xref: | EFO:0002687 |
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22749977 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcc5 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
|
ISO |
mRNA, protein:increased expression:brain, neuron |
RGD |
PMID:16997484 |
RGD:2301088 |
NCBI chr16:20,150,053...20,245,178
Ensembl chr16:20,150,053...20,245,144
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
|
ISO |
mRNA, protein:increased expression, altered localization:small intestine |
RGD |
PMID:18451542 |
RGD:2315580 |
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
|
|
G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
ISO |
|
RGD |
PMID:20436217 |
RGD:2325213 |
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
ISO |
mRNA:increased expression:hippocampal granule cell |
RGD |
PMID:19647005 |
RGD:2315956 |
NCBI chr17:93,506,448...93,513,967
Ensembl chr17:93,506,445...93,513,965
|
|
G |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
|
ISO |
mRNA:decreased expression:dentate gyrus (rat) |
RGD |
PMID:19647005 |
RGD:2315956 |
NCBI chr 6:55,428,486...55,478,440
Ensembl chr 6:55,428,963...55,478,436
|
|
G |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
|
ISO |
|
RGD |
PMID:12225880 |
RGD:2314400 |
NCBI chr 8:84,626,598...84,668,583
Ensembl chr 8:84,626,734...84,668,583
|
|
G |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
|
ISO |
|
RGD |
PMID:12225880 |
RGD:2314400 |
NCBI chr 5:81,167,600...81,980,556
Ensembl chr 5:81,167,985...81,972,980
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
associated with Non-alcoholic Fatty Liver Disease; |
RGD |
PMID:18098300 |
RGD:5686804 |
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
|
|
G |
Adm |
adrenomedullin |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:17263982 |
RGD:7364988 |
NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:27757725 PMID:17937935 |
RGD:4890367 |
NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
|
|
G |
Adora2b |
adenosine A2b receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27757725 |
|
NCBI chr11:62,139,810...62,157,278
Ensembl chr11:62,139,810...62,157,279
|
|
G |
Adrb1 |
adrenergic receptor, beta 1 |
|
ISO |
|
RGD |
PMID:20451506 |
RGD:5129116 |
NCBI chr19:56,710,549...56,713,582
Ensembl chr19:56,710,631...56,721,545
|
|
G |
Adrb2 |
adrenergic receptor, beta 2 |
|
ISO |
|
RGD |
PMID:14630341 PMID:18336819 |
RGD:1598754, RGD:4145097 |
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
|
|
G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
|
ISO |
|
RGD |
PMID:22920387 |
RGD:6903870 |
NCBI chr X:21,350,863...21,355,072
Ensembl chr X:21,350,783...21,355,403
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
ISO |
protein:increased expression:Kupffer cell (rat) |
RGD |
PMID:16500929 |
RGD:2313040 |
NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
IMP |
|
RGD |
PMID:21351045 |
RGD:5509067 |
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Akt1s1 |
AKT1 substrate 1 (proline-rich) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16397181 |
|
NCBI chr 7:44,498,648...44,504,845
Ensembl chr 7:44,498,415...44,504,845
|
|
G |
Alb |
albumin |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:20193666 |
RGD:2325686 |
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
ISO |
|
RGD |
PMID:10395295 |
RGD:1599061 |
NCBI chr 7:126,394,406...126,399,537
Ensembl chr 7:126,394,406...126,399,923 Ensembl chr 7:126,394,406...126,399,923
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase |
|
ISO |
|
RGD |
PMID:15518705 |
RGD:5509617 |
NCBI chr11:70,132,283...70,146,206
Ensembl chr11:70,132,283...70,146,179
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
IMP |
|
RGD |
PMID:18635843 |
RGD:5509608 |
NCBI chr11:70,234,973...70,279,465
Ensembl chr11:70,234,978...70,242,857
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:cerebral hemisphere CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15266012 PMID:14769366 PMID:19816089 |
RGD:1626152, RGD:2317531 |
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
|
|
G |
Ang |
angiogenin, ribonuclease, RNase A family, 5 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:19666176 |
RGD:2325717 |
NCBI chr14:51,328,607...51,339,462
Ensembl chr14:51,328,607...51,339,466
|
|
G |
Angpt1 |
angiopoietin 1 |
|
ISO |
|
RGD |
PMID:19885826 |
RGD:2316041 |
NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
|
ISO |
|
RGD |
PMID:16339390 |
RGD:2313821 |
NCBI chr11:101,221,432...101,230,256
Ensembl chr11:101,221,431...101,232,764
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
ISO |
|
RGD |
PMID:18205898 |
RGD:2292105 |
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
Apex1 |
apurinic/apyrimidinic endonuclease 1 |
|
ISO |
protein:increased expression:placenta |
RGD |
PMID:18373555 |
RGD:2315671 |
NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO IDA IMP |
protein:increased expression:cerebral cortex mRNA, protein:increased expression:parietal cortex |
RGD |
PMID:20979759 PMID:21718723 PMID:19806476 PMID:20924629 |
RGD:5148016, RGD:5684013, RGD:5148037, RGD:5148022 |
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
|
|
G |
Arg1 |
arginase, liver |
|
ISO |
protein:increased expression:serum (rat) |
RGD |
PMID:17023552 |
RGD:4143185 |
NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382
|
|
G |
Asl |
argininosuccinate lyase |
resistance |
ISO |
protein:increased expression:brain, neuron (rat) |
RGD |
PMID:17198704 |
RGD:1599263 |
NCBI chr 5:130,040,099...130,053,222
Ensembl chr 5:130,040,099...130,058,088
|
|
G |
Ass1 |
argininosuccinate synthetase 1 |
resistance |
ISO |
protein:increased expression:brain, neuron (rat) |
RGD |
PMID:17198704 |
RGD:1599263 |
NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
|
|
G |
Bad |
BCL2-associated agonist of cell death |
|
ISO |
protein:altered localization:brain, mitochondria |
RGD |
PMID:18347331 |
RGD:2292679 |
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
|
|
G |
Bag1 |
BCL2-associated athanogene 1 |
|
ISO |
|
RGD |
PMID:12215270 |
RGD:2296021 |
NCBI chr 4:40,936,398...40,948,294
Ensembl chr 4:40,936,398...40,948,294
|
|
G |
Bag3 |
BCL2-associated athanogene 3 |
|
ISO |
protein:increased expression:hippocampus, astrocyte |
RGD |
PMID:12061864 |
RGD:2325848 |
NCBI chr 7:128,125,307...128,148,705
Ensembl chr 7:128,125,340...128,148,705
|
|
G |
Bax |
BCL2-associated X protein |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:18221257 PMID:18083315 |
RGD:2293026, RGD:2290557 |
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15449323 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bdnf |
brain derived neurotrophic factor |
|
ISO |
mRNA:increased expression:retina |
RGD |
PMID:20554625 |
RGD:4891135 |
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
|
|
G |
Becn1 |
beclin 1, autophagy related |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:22306244 |
RGD:6483054 |
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
ISO |
|
RGD |
PMID:19888517 |
RGD:2317562 |
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:18159002 |
RGD:2293126 |
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
|
ISO |
|
RGD |
PMID:11245809 |
RGD:2289024 |
NCBI chr13:38,529,098...38,684,283
Ensembl chr13:38,529,083...38,684,278
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
ISO |
mRNA:increased expression:dentate gyrus, granule cell |
RGD |
PMID:10996456 |
RGD:5129486 |
NCBI chr 1:59,802,721...59,917,240
Ensembl chr 1:59,802,559...59,918,173
|
|
G |
Bsg |
basigin |
|
ISO |
protein:increased expression:basal ganglia |
RGD |
PMID:16029217 |
RGD:2289063 |
NCBI chr10:79,540,192...79,547,813
Ensembl chr10:79,540,325...79,547,803
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:9712737 |
RGD:2289078 |
NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
|
|
G |
C3 |
complement component 3 |
|
ISO |
protein:increased expression:intestine |
RGD |
PMID:17981193 |
RGD:5129536 |
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
C3ar1 |
complement component 3a receptor 1 |
|
ISO |
|
RGD |
PMID:15159277 |
RGD:5129702 |
NCBI chr 6:122,824,099...122,833,116
Ensembl chr 6:122,824,097...122,833,120
|
|
G |
C5ar1 |
complement component 5a receptor 1 |
|
ISO |
|
RGD |
PMID:15158333 PMID:15159277 |
RGD:1600597, RGD:5129702 |
NCBI chr 7:15,980,668...15,993,465
Ensembl chr 7:15,980,668...15,993,465
|
|
G |
Casp1 |
caspase 1 |
|
ISO |
|
RGD |
PMID:17845807 |
RGD:2315890 |
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Casp12 |
caspase 12 |
|
ISO |
|
RGD |
PMID:18273070 |
RGD:2311461 |
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23875703 PMID:18490106 PMID:29568770 |
RGD:2293311, RGD:13792595 |
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp6 |
caspase 6 |
|
ISO |
protein:increased expression, increased activity:small intestine mucosa |
RGD |
PMID:15010362 |
RGD:2301320 |
NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chr 1:58,834,398...58,886,662
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:29568770 |
RGD:13792595 |
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cast |
calpastatin |
|
ISO |
|
RGD |
PMID:11035539 |
RGD:5509823 |
NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:8215636 PMID:16682413 PMID:23743330 PMID:23875703 PMID:19196076 PMID:20888583 More...
|
RGD:5130760, RGD:5130200 |
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Cav1 |
caveolin 1, caveolae protein |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:17293479 |
RGD:2289123 |
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
|
|
G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
ISO |
mRNA:increased expression:aorta |
RGD |
PMID:9665468 |
RGD:4145482 |
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
|
|
G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
treatment |
ISO |
Gastric Reperfusion Injury CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12468449 PMID:15829914 PMID:22611311 |
RGD:8549744 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15829914 |
|
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
|
|
G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
ISO IEP |
protein:increased expression:gut protein:increased secretion:lung, secretion (mouse) |
RGD |
PMID:15542513 PMID:19558673 |
RGD:2307184, RGD:4891479 |
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccnb1 |
cyclin B1 |
|
ISO |
protein;altered expression:cerebral cortex, hippocampus CA1, neuron |
RGD |
PMID:18278459 |
RGD:2315990 |
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
|
RGD |
PMID:16718823 |
RGD:2289145 |
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Ccne1 |
cyclin E1 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:17584601 |
RGD:2289275 |
NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
|
|
G |
Ccng1 |
cyclin G1 |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:9698156 |
RGD:2316027 |
NCBI chr11:40,639,379...40,646,044
Ensembl chr11:40,639,379...40,646,138
|
|
G |
Ccr1 |
chemokine (C-C motif) receptor 1 |
|
IEP |
mRNA:increased expression:kidney |
RGD |
PMID:20410256 |
RGD:5688141 |
NCBI chr 9:123,762,163...123,768,729
Ensembl chr 9:123,762,161...123,768,729
|
|
G |
Cd2ap |
CD2-associated protein |
|
ISO |
|
RGD |
PMID:16088078 |
RGD:1581187 |
NCBI chr17:43,059,857...43,187,593
Ensembl chr17:43,103,842...43,187,556
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 5:17,986,688...18,093,957
Ensembl chr 5:17,986,688...18,093,799
|
|
G |
Cd40 |
CD40 antigen |
|
ISO |
|
RGD |
PMID:12388354 |
RGD:5508171 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd40lg |
CD40 ligand |
|
IMP ISO |
|
RGD |
PMID:20659085 PMID:12388354 |
RGD:5490531, RGD:5508171 |
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
|
|
G |
Cd44 |
CD44 antigen |
|
ISO |
protein:increased expression:kidney protein:increased expression:testis, macrophage |
RGD |
PMID:16786159 PMID:16891795 |
RGD:2289354, RGD:2289369 |
NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
|
|
G |
Cd55 |
CD55 molecule, decay accelerating factor for complement |
|
ISO |
|
RGD |
PMID:20403613 |
RGD:2326175 |
NCBI chr 1:130,357,526...130,390,513
Ensembl chr 1:130,366,764...130,390,481
|
|
G |
Cd59a |
CD59a antigen |
|
ISO |
|
RGD |
PMID:10530491 |
RGD:1600493 |
NCBI chr 2:103,926,177...103,945,755
Ensembl chr 2:103,926,146...103,945,699
|
|
G |
Cd59b |
CD59b antigen |
|
ISO |
|
RGD |
PMID:10530491 |
RGD:1600493 |
NCBI chr 2:103,900,127...103,920,619
Ensembl chr 2:103,900,194...103,921,532
|
|
G |
Cdc42 |
cell division cycle 42 |
|
ISO |
protein:increased activation:hippocampus CA1 |
RGD |
PMID:17161586 |
RGD:2298583 |
NCBI chr 4:137,047,007...137,085,070
Ensembl chr 4:137,047,007...137,085,031
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A (P21) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16968891 PMID:10451498 |
RGD:10043817 |
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
|
ISO |
protein:increased expression:skeletal muscle |
RGD |
PMID:15799773 |
RGD:2293627 |
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
|
|
G |
Cfh |
complement component factor h |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:17263982 |
RGD:7364988 |
NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
|
|
G |
Chat |
choline acetyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chr14:32,130,160...32,187,866
Ensembl chr14:32,130,160...32,187,946
|
|
G |
Cldn4 |
claudin 4 |
|
ISO |
protein:increased expression, altered localization:small intestine epithelium |
RGD |
PMID:17375208 |
RGD:2317600 |
NCBI chr 5:134,973,977...134,975,788
Ensembl chr 5:134,973,973...134,975,788
|
|
G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
ISO |
|
RGD |
PMID:19372445 |
RGD:2314674 |
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
ISO |
|
RGD |
PMID:17565360 |
RGD:5686869 |
NCBI chr 9:56,772,388...56,807,154
Ensembl chr 9:56,772,317...56,807,154
|
|
G |
Ctsb |
cathepsin B |
|
ISO |
protein:increased expression:cerebral cortex, mitochondrion (rat) |
RGD |
PMID:18938146 |
RGD:2315506 |
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
|
|
G |
Ctsg |
cathepsin G |
|
IMP |
|
RGD |
PMID:17322378 |
RGD:7242055 |
NCBI chr14:56,337,342...56,340,031
Ensembl chr14:56,337,338...56,340,031
|
|
G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:19563789 |
RGD:4891956 |
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
|
|
G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
IEP ISO |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16526316 PMID:20160675 PMID:10655268 |
RGD:5134970, RGD:5135270 |
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
ISO IEP |
mRNA:increased expression:liver protein:increased expression:respiratory system fluid/secretion associated with Anemia, Sickle Cell;protein:increased expression:lung |
RGD |
PMID:18589091 PMID:16709871 PMID:19433855 |
RGD:2311376, RGD:5135441, RGD:5135307 |
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
ISO |
protein:increased expression:retina |
RGD |
PMID:18709383 |
RGD:2306570 |
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
|
|
G |
Cxcl15 |
chemokine (C-X-C motif) ligand 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12865660 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
ISO IEP |
mRNA:increased expression:jejunum, lung CTD Direct Evidence: marker/mechanism protein:increased expression:liver mRNA:increased expression:liver |
CTD RGD |
PMID:12468449 PMID:19691980 PMID:10655268 PMID:11580116 PMID:20160675 |
RGD:5134974, RGD:5135270, RGD:5135251, RGD:5134970 |
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
|
|
G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:11580116 PMID:10655268 |
RGD:5135251, RGD:5135270 |
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
|
|
G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
IEP |
associated with Anemia, Sickle Cell;protein:increased expression:lung |
RGD |
PMID:19433855 |
RGD:5135307 |
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
|
|
G |
Cxcr3 |
chemokine (C-X-C motif) receptor 3 |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:18589091 |
RGD:2311376 |
NCBI chr X:100,775,141...100,777,753
Ensembl chr X:100,775,141...100,777,875
|
|
G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
ISO |
|
RGD |
PMID:15148062 |
RGD:1599683 |
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
|
|
G |
Cybb |
cytochrome b-245, beta polypeptide |
|
ISO |
Protein:increase expression:brain CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19193722 PMID:16766636 |
RGD:1599677 |
NCBI chr X:9,301,493...9,354,005
Ensembl chr X:9,301,491...9,354,010
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
ISO |
protein:increased expression:hippocampus (rat) |
RGD |
PMID:21114983 |
RGD:4890041 |
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:21094789 |
RGD:4892235 |
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
G |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22749977 |
|
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:18790177 |
RGD:4781446 |
NCBI chr X:105,617,952...105,647,329
Ensembl chr X:105,617,952...105,647,285
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:21664436 |
RGD:5144004 |
NCBI chr14:73,263,043...73,286,554
Ensembl chr14:73,263,043...73,286,554
|
|
G |
Dcc |
deleted in colorectal carcinoma |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:17574219 |
RGD:2314372 |
NCBI chr18:71,386,703...72,484,299
Ensembl chr18:71,386,705...72,484,140
|
|
G |
Dsg1a |
desmoglein 1 alpha |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:19500802 |
RGD:2316254 |
NCBI chr18:20,443,930...20,476,410
Ensembl chr18:20,443,868...20,476,407
|
|
G |
Dsg1b |
desmoglein 1 beta |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:19500802 |
RGD:2316254 |
NCBI chr18:20,509,786...20,545,240
Ensembl chr18:20,509,786...20,543,253
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17470888 PMID:18722366 |
RGD:4892577 |
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
|
|
G |
Edn2 |
endothelin 2 |
|
ISO |
|
RGD |
PMID:1479622 |
RGD:1580920 |
NCBI chr 4:120,018,403...120,024,557
Ensembl chr 4:120,018,403...120,024,557
|
|
G |
Ednrb |
endothelin receptor type B |
|
ISO |
|
RGD |
PMID:18722366 |
RGD:4892577 |
NCBI chr14:104,052,051...104,083,248
Ensembl chr14:104,052,061...104,081,838
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
ISO |
protein:hypophosphorylation:cortex, hippocampus: |
RGD |
PMID:15211596 |
RGD:10401223 |
NCBI chr10:81,012,465...81,018,343
Ensembl chr10:81,012,465...81,018,332
|
|
G |
Efna5 |
ephrin A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr17:62,909,949...63,188,431
Ensembl chr17:62,911,179...63,188,312
|
|
G |
Efnb2 |
ephrin B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 8:8,667,235...8,711,242
Ensembl chr 8:8,667,434...8,711,242
|
|
G |
Egf |
epidermal growth factor |
resistance |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16526316 PMID:16417467 |
RGD:6906916 |
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
|
|
G |
Egr1 |
early growth response 1 |
|
IEP ISO IMP |
Lung Reperfusion Injury; protein:increased expression:lung, nucleus (mouse) CTD Direct Evidence: marker/mechanism Lung Reperfusion Injury; protein:increased expression:lung, nucleus (rat) |
CTD RGD |
PMID:12468449 PMID:19342415 PMID:16488723 PMID:16551742 |
RGD:5131887, RGD:5131904, RGD:5131903 |
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19041636 |
|
NCBI chr 3:58,433,252...58,464,922
Ensembl chr 3:58,433,242...58,464,922
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
ISO |
protein:increased phosphorylation:kidney |
RGD |
PMID:15936177 |
RGD:1581062 |
NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
ISO |
protein:increased phosphorylation:kidney |
RGD |
PMID:15936177 |
RGD:1581062 |
NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
|
|
G |
Eno2 |
enolase 2, gamma neuronal |
|
ISO |
|
RGD |
PMID:17683050 |
RGD:2293745 |
NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636
|
|
G |
Ep300 |
E1A binding protein p300 |
treatment |
ISO |
retina retina; protein:altered localization:Hsp70, promoter (rat) |
RGD |
PMID:22143029 PMID:22143029 |
RGD:5686888, RGD:5686888 |
NCBI chr15:81,470,329...81,536,278
Ensembl chr15:81,469,552...81,536,278
|
|
G |
Epha2 |
Eph receptor A2 |
|
ISO |
|
RGD |
PMID:16735461 |
RGD:1580976 |
NCBI chr 4:141,028,532...141,056,695
Ensembl chr 4:141,028,551...141,056,695
|
|
G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
IMP |
|
RGD |
PMID:19471280 |
RGD:5688359 |
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
|
|
G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
|
ISO |
|
RGD |
PMID:19440222 |
RGD:2313668 |
NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449
|
|
G |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 9:32,547,501...32,669,116
Ensembl chr 9:32,547,517...32,669,116
|
|
G |
F2 |
coagulation factor II |
|
ISO |
|
RGD |
PMID:20705928 |
RGD:5147777 |
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
|
|
G |
Fas |
Fas (TNF receptor superfamily member 6) |
treatment |
ISO |
|
RGD |
PMID:29568770 |
RGD:13792595 |
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
|
ISO |
Rat model using human FGF1 |
RGD |
PMID:19497570 PMID:16635575 |
RGD:5509879, RGD:5509881 |
NCBI chr18:38,971,725...39,062,532
Ensembl chr18:38,971,726...39,062,525
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 2:125,876,578...125,933,105
Ensembl chr 2:125,876,578...125,933,105
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
|
ISO |
protein:increased expression:brain CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:7922267 PMID:15121240 |
RGD:2293779 |
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Fosl1 |
fos-like antigen 1 |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:15306117 |
RGD:1642465 |
NCBI chr19:5,497,726...5,505,966
Ensembl chr19:5,497,575...5,505,974
|
|
G |
Fosl2 |
fos-like antigen 2 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:15121240 |
RGD:2293779 |
NCBI chr 5:32,292,599...32,315,184
Ensembl chr 5:32,293,145...32,315,186
|
|
G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
|
ISO |
|
RGD |
PMID:17250641 |
RGD:2307361 |
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
|
|
G |
Gast |
gastrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10594344 |
|
NCBI chr11:100,225,233...100,227,823
Ensembl chr11:100,225,233...100,227,822
|
|
G |
Gh |
growth hormone |
treatment |
ISO |
|
RGD |
PMID:21439711 |
RGD:10003153 |
NCBI chr11:106,191,087...106,194,529
Ensembl chr11:106,191,097...106,192,691
|
|
G |
Ghrl |
ghrelin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16581065 |
|
NCBI chr 6:113,693,080...113,696,872
Ensembl chr 6:113,693,080...113,696,841
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25530438 |
|
NCBI chr X:100,419,982...100,429,235
Ensembl chr X:100,419,984...100,429,235
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
|
ISO |
protein:decreased activity:brain |
RGD |
PMID:7808037 |
RGD:6484655 |
NCBI chr14:34,032,684...34,066,990
Ensembl chr14:34,032,684...34,067,222
|
|
G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
|
ISO |
|
RGD |
PMID:11367746 |
RGD:13513922 |
NCBI chr 9:107,491,324...107,512,542
Ensembl chr 9:107,491,324...107,512,566
|
|
G |
Gnai3 |
guanine nucleotide binding protein (G protein), alpha inhibiting 3 |
|
ISO |
|
RGD |
PMID:11367746 |
RGD:13513922 |
NCBI chr 3:108,014,591...108,053,468
Ensembl chr 3:108,014,596...108,053,462
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8215636 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23743330 |
|
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
|
ISO |
mRNA:decreased expression:hippocampus (rat) |
RGD |
PMID:20408958 |
RGD:4107069 |
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
|
|
G |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
|
ISO |
|
RGD |
PMID:17639597 |
RGD:2316528 |
NCBI chr10:48,969,776...49,666,523
Ensembl chr10:48,970,929...49,664,862
|
|
G |
Grik5 |
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
|
ISO |
|
RGD |
PMID:17639597 |
RGD:2316528 |
NCBI chr 7:24,709,274...24,775,421
Ensembl chr 7:24,709,274...24,771,771
|
|
G |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat) |
RGD |
PMID:20350575 |
RGD:2325867 |
NCBI chr16:9,385,765...9,813,744
Ensembl chr16:9,385,762...9,813,424
|
|
G |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat) |
RGD |
PMID:20350575 |
RGD:2325867 |
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
|
|
G |
Gsr |
glutathione reductase |
treatment |
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:24904723 |
RGD:10401882 |
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
|
IEP |
|
RGD |
PMID:17142801 |
RGD:6903953 |
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7635938 |
|
NCBI chr18:36,637,980...36,648,858
Ensembl chr18:36,637,980...36,648,858
|
|
G |
Hc |
hemolytic complement |
|
ISO |
|
RGD |
PMID:15158333 |
RGD:1600597 |
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
|
|
G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
treatment |
ISO |
Spinal Cord Reperfusion Injury Limb Reperfusion Injury |
RGD |
PMID:16465055 PMID:23816242 |
RGD:9068924, RGD:9068927 |
NCBI chr12:73,948,098...73,994,328
Ensembl chr12:73,948,149...73,994,304
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
|
RGD |
PMID:22392147 |
RGD:10402071 |
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
|
ISO IMP |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:21724106 PMID:16009498 PMID:18398369 |
RGD:5508445, RGD:5508473, RGD:2315888 |
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic protein:increased expression:serum, Bronchoalveolar Lavage Fluid |
CTD RGD |
PMID:12352873 PMID:16982915 PMID:17660127 PMID:17906103 PMID:23075401 PMID:25780291 PMID:16699460 PMID:12919086 PMID:19885035 More...
|
RGD:1582708, RGD:4145514, RGD:4145338 |
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hrh3 |
histamine receptor H3 |
|
ISO |
|
RGD |
PMID:17169356 |
RGD:1626416 |
NCBI chr 2:179,741,258...179,746,264
Ensembl chr 2:179,741,258...179,746,281
|
|
G |
Hspa1a |
heat shock protein 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7922267 |
|
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
|
|
G |
Hspa1b |
heat shock protein 1B |
|
ISO |
|
RGD |
PMID:10965299 PMID:10550516 |
RGD:7242748, RGD:7242749 |
NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
|
|
G |
Hspa5 |
heat shock protein 5 |
|
ISO |
associated with Diabetes Mellitus, experimental (D003921): protein:increased expression:brain |
RGD |
PMID:22075494 |
RGD:5685650 |
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Hspa8 |
heat shock protein 8 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10216529 |
|
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
|
|
G |
Hspb1 |
heat shock protein 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19193722 |
|
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11557319 PMID:23743330 |
|
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 4:135,871,133...135,872,703
Ensembl chr 4:135,870,808...135,873,066
|
|
G |
Ifng |
interferon gamma |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:19514843 |
RGD:2308950 |
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
IEP |
|
RGD |
PMID:16306169 |
RGD:1598442 |
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18460982 PMID:19514843 PMID:12388354 PMID:16141682 |
RGD:2308950, RGD:5508171, RGD:1598625 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il12a |
interleukin 12a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 3:68,597,977...68,605,881
Ensembl chr 3:68,597,977...68,605,880
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:18354382 PMID:18354382 |
RGD:2301685, RGD:2301685 |
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
|
|
G |
Il18 |
interleukin 18 |
|
IMP IEP |
protein:increased expression:serum |
RGD |
PMID:19394645 PMID:16052682 |
RGD:4889555, RGD:4889825 |
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10594344 PMID:12468449 PMID:15829914 PMID:19058328 PMID:19673871 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il6 |
interleukin 6 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:lung |
CTD RGD |
PMID:15829914 PMID:17032661 PMID:18258783 PMID:19673871 PMID:21940958 PMID:20680426 PMID:20659747 More...
|
RGD:4143250, RGD:4143253 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Il6ra |
interleukin 6 receptor, alpha |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503
|
|
G |
Il6st |
interleukin 6 signal transducer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chr13:112,600,604...112,643,394
Ensembl chr13:112,600,604...112,646,620
|
|
G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chr 1:87,548,034...87,648,232
Ensembl chr 1:87,548,034...87,648,229
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chr10:119,977,553...120,038,035
Ensembl chr10:119,977,553...120,038,035
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
ISO |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chr11:53,660,841...53,669,200
Ensembl chr11:53,660,841...53,669,200
|
|
G |
Itga2b |
integrin alpha 2b |
|
ISO |
|
RGD |
PMID:11705748 |
RGD:2316361 |
NCBI chr11:102,344,123...102,360,709
Ensembl chr11:102,344,123...102,360,948
|
|
G |
Itga5 |
integrin alpha 5 (fibronectin receptor alpha) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr15:103,252,713...103,275,218
Ensembl chr15:103,252,713...103,275,190
|
|
G |
Itgb3 |
integrin beta 3 |
|
ISO |
|
RGD |
PMID:11705748 |
RGD:2316361 |
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
|
|
G |
Jak2 |
Janus kinase 2 |
|
IMP |
|
RGD |
PMID:20440769 |
RGD:6483026 |
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
|
|
G |
Jun |
jun proto-oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7922267 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
ISO |
|
RGD |
PMID:10708603 |
RGD:1581697 |
NCBI chr 6:142,510,563...142,517,340
Ensembl chr 6:142,510,563...142,517,340
|
|
G |
Kdr |
kinase insert domain protein receptor |
|
ISO |
mRNA:increased expression:hippocampus CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16526316 PMID:17402857 |
RGD:5684415 |
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
|
|
G |
Keap1 |
kelch-like ECH-associated protein 1 |
|
IEP ISO |
protein:decreased expression:brain, neuron, cytoplasm (mouse) protein:decreased expression:left coronary artery (rat) |
RGD |
PMID:21075092 PMID:18078953 |
RGD:6893270, RGD:6902919 |
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
|
|
G |
Klk1 |
kallikrein 1 |
|
ISO |
|
RGD |
PMID:12746231 |
RGD:1641806 |
NCBI chr 7:43,874,784...43,879,046
Ensembl chr 7:43,874,784...43,879,042
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
ISO |
|
RGD |
PMID:17288738 |
RGD:2324630 |
NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215
|
|
G |
Lep |
leptin |
|
ISO |
|
RGD |
PMID:21086559 |
RGD:5128549 |
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
|
|
G |
Lig3 |
ligase III, DNA, ATP-dependent |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chr11:82,671,977...82,695,100
Ensembl chr11:82,671,934...82,695,100
|
|
G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:19773801 |
RGD:2325809 |
NCBI chr 9:106,765,952...106,769,137
Ensembl chr 9:106,715,511...106,769,178
|
|
G |
Map2 |
microtubule-associated protein 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21948028 |
RGD:6483082 |
NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20302854 PMID:16699462 |
RGD:1582310 |
NCBI chr14:33,099,855...33,169,215
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
|
ISO |
protein:increased activity:hippocampus |
RGD |
PMID:16805806 |
RGD:2293339 |
NCBI chr17:25,116,480...25,155,951
Ensembl chr17:25,111,127...25,155,951
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19667931 PMID:20302854 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mb |
myoglobin |
|
ISO |
|
RGD |
PMID:12788661 |
RGD:1582427 |
NCBI chr15:76,899,687...76,934,868
Ensembl chr15:76,899,687...76,934,870
|
|
G |
Mbl1 |
mannose-binding lectin (protein A) 1 |
|
IMP IEP |
protein:decreased expression:serum |
RGD |
PMID:16982912 PMID:15509537 |
RGD:1582132, RGD:6903263 |
NCBI chr14:40,873,413...40,885,861
Ensembl chr14:40,873,415...40,881,558
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
ISO IEP |
protein:increased expression:serum |
RGD |
PMID:15882434 PMID:15509537 |
RGD:6903262, RGD:6903263 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
Mc1r |
melanocortin 1 receptor |
no_association |
IEP |
|
RGD |
PMID:18757499 |
RGD:5687323 |
NCBI chr 8:124,133,839...124,137,483
Ensembl chr 8:124,133,846...124,137,483
|
|
G |
Mdk |
midkine |
|
IDA |
|
RGD |
PMID:15780085 |
RGD:1582475 |
NCBI chr 2:91,760,149...91,762,348
Ensembl chr 2:91,760,150...91,762,642
|
|
G |
Met |
met proto-oncogene |
|
ISO |
mRNA:increased expression:retina (rat) |
RGD |
PMID:17113948 |
RGD:2317505 |
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
|
|
G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
disease_progression |
IMP |
|
RGD |
PMID:18055556 |
RGD:4891010 |
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
|
|
G |
Mir148b |
microRNA 148b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30308185 |
|
NCBI chr15:103,193,552...103,193,648
Ensembl chr15:103,193,552...103,193,648
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
|
ISO |
protein:increased protein, activity:brain |
RGD |
PMID:15099024 |
RGD:2325962 |
NCBI chr 9:7,445,822...7,455,975
Ensembl chr 9:7,445,822...7,455,975
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP ISO IDA |
protein:increased expression:limb muscle (mouse) CTD Direct Evidence: marker/mechanism associated with lung injury; mRNA, protein:increased expression:lung |
CTD RGD |
PMID:23075401 PMID:16251419 PMID:19545667 PMID:16551680 |
RGD:1582631, RGD:5129531, RGD:1582618 |
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
protein:increased activity:lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:8869312 PMID:10706834 PMID:12024109 PMID:16971220 PMID:19058328 PMID:20863214 PMID:21470877 More...
|
RGD:5130958 |
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
mt-Atp6 |
ATP synthase 6, mitochondrial |
|
ISO |
|
RGD |
PMID:20450733 |
RGD:5490294 |
NCBI chr MT:7,927...8,607
Ensembl chr MT:7,927...8,607
|
|
G |
mt-Atp8 |
ATP synthase 8, mitochondrial |
|
ISO |
|
RGD |
PMID:20450733 |
RGD:5490294 |
NCBI chr MT:7,766...7,969
Ensembl chr MT:7,766...7,969
|
|
G |
mt-Cytb |
cytochrome b, mitochondrial |
|
ISO |
mRNA:decreased expression:kidney |
RGD |
PMID:7692737 |
RGD:2298967 |
NCBI chr MT:14,145...15,288
Ensembl chr MT:14,145...15,288
|
|
G |
Mt2 |
metallothionein 2 |
|
IEP |
mRNA:increased expression:cerebrum (mouse) |
RGD |
PMID:12122050 |
RGD:6483850 |
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
|
|
G |
Mt3 |
metallothionein 3 |
|
IMP |
|
RGD |
PMID:19635467 |
RGD:6480529 |
NCBI chr 8:94,879,235...94,880,776
Ensembl chr 8:94,879,235...94,880,774
|
|
G |
Muc1 |
mucin 1, transmembrane |
|
ISO |
|
RGD |
PMID:23977093 |
RGD:7349380 |
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25780291 |
|
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
|
|
G |
Nes |
nestin |
|
ISO |
protein:increased expression:cerebral cortex |
RGD |
PMID:17569338 |
RGD:1642074 |
NCBI chr 3:87,878,400...87,887,758
Ensembl chr 3:87,878,385...87,887,758
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
ISO |
protein:increased expression:small intestine |
RGD |
PMID:20107953 |
RGD:5131440 |
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
|
|
G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
ISO |
|
RGD |
PMID:17451676 |
RGD:1642142 |
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
|
ISO IEP |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism protein:increased expression:venule, arteriole, endothelium (mouse) mRNA, protein:increased expression:liver |
CTD RGD |
PMID:10383581 PMID:19673871 PMID:23061969 PMID:23075401 PMID:11592783 PMID:22019501 PMID:14599979 More...
|
RGD:2325259, RGD:5509100, RGD:1580938 |
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21968084 |
|
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Nox4 |
NADPH oxidase 4 |
|
ISO |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:18438942 |
RGD:2324666 |
NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
|
|
G |
Oga |
O-GlcNAcase |
|
ISO |
|
RGD |
PMID:16899550 |
RGD:2305957 |
NCBI chr19:45,738,698...45,772,274
Ensembl chr19:45,738,698...45,772,276
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
|
ISO |
mRNA, protein:decreased expression:hippocampus |
RGD |
PMID:17360495 |
RGD:2316611 |
NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198
|
|
G |
Otc |
ornithine transcarbamylase |
|
ISO |
protein:increased activity:serum |
RGD |
PMID:1499453 |
RGD:4144083 |
NCBI chr X:10,118,584...10,187,275
Ensembl chr X:10,118,544...10,187,263
|
|
G |
Oxt |
oxytocin |
|
ISO |
|
RGD |
PMID:18403049 |
RGD:2304111 |
NCBI chr 2:130,416,432...130,418,974
Ensembl chr 2:130,418,093...130,418,974
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (rat) |
CTD RGD |
PMID:15696051 PMID:16798486 PMID:9390645 PMID:21850691 |
RGD:5510018, RGD:5510020 |
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
ISO IMP |
|
RGD |
PMID:19142196 PMID:19142196 |
RGD:6483555, RGD:6483555 |
NCBI chr 2:143,388,053...143,658,204
Ensembl chr 2:143,388,076...143,658,205
|
|
G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
ISO |
|
RGD |
PMID:19474186 |
RGD:2314462 |
NCBI chr 3:122,522,822...122,653,023
Ensembl chr 3:122,522,596...122,653,023
|
|
G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
ISO IEP |
protein:decreased expression:lung (rat) protein:increased expression:brain (mouse) |
RGD |
PMID:12121711 PMID:21872880 PMID:22382321 |
RGD:2311660, RGD:6771206, RGD:6766379 |
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
ISO |
proetin:decreased dimerization:skeletal muscle (rat) |
RGD |
PMID:19100383 |
RGD:4108481 |
NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725
|
|
G |
Pink1 |
PTEN induced putative kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35312153 |
|
NCBI chr 4:138,040,718...138,053,631
Ensembl chr 4:138,040,720...138,053,618
|
|
G |
Pklr |
pyruvate kinase liver and red blood cell |
|
ISO |
|
RGD |
PMID:17013507 |
RGD:1625588 |
NCBI chr 3:89,043,429...89,054,122
Ensembl chr 3:89,043,449...89,054,091
|
|
G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12967936 |
|
NCBI chr 4:138,559,168...138,562,500
Ensembl chr 4:138,559,171...138,562,497
|
|
G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
ISO |
protein:increased activity:alveolar macrophage |
RGD |
PMID:1642455 |
RGD:1642456 |
NCBI chr 1:149,705,369...149,837,041
Ensembl chr 1:149,705,369...149,837,041
|
|
G |
Plat |
plasminogen activator, tissue |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:9472885 PMID:15223382 |
RGD:2311674 |
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO IDA |
protein:increased expression:spinal cord (rat) CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:15181847 PMID:19663807 PMID:18586014 |
RGD:6483808, RGD:6483830 |
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
|
IMP |
|
RGD |
PMID:18606671 |
RGD:6483829 |
NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393
|
|
G |
Pld2 |
phospholipase D2 |
|
ISO |
protein:increased expression:hippocampus CA1, hippocampus granule cell layer mRNA:decreased expression:brainstem, cerebellum |
RGD |
PMID:17393174 PMID:17024567 |
RGD:2299901, RGD:2299902 |
NCBI chr11:70,430,318...70,448,936
Ensembl chr11:70,430,890...70,448,936
|
|
G |
Pnmt |
phenylethanolamine-N-methyltransferase |
|
ISO |
protein:increased expression:medulla oblongata (human) |
RGD |
PMID:21061149 |
RGD:5128821 |
NCBI chr11:98,277,449...98,279,006
Ensembl chr11:98,277,276...98,279,007
|
|
G |
Polb |
polymerase (DNA directed), beta |
|
ISO |
protein:increased expression:cerebral cortex |
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chr 8:23,118,135...23,143,482
Ensembl chr 8:23,118,142...23,143,451
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
liver ischemia/reperfusion injury (rat) CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:19151258 PMID:21305343 |
RGD:5509942 |
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12468449 PMID:24011919 PMID:24433871 |
|
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isoform |
|
ISO |
|
RGD |
PMID:14762344 |
RGD:1580702 |
NCBI chr 3:136,375,778...136,643,488
Ensembl chr 3:136,375,885...136,643,488
|
|
G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isoform |
|
IAGP |
|
RGD |
PMID:14615291 |
RGD:1580705 |
NCBI chr14:20,549,432...20,596,641
Ensembl chr14:20,549,432...20,596,641
|
|
G |
Prdx6 |
peroxiredoxin 6 |
|
IAGP |
|
RGD |
PMID:16766642 |
RGD:1580710 |
NCBI chr 1:161,067,682...161,078,780
Ensembl chr 1:161,067,682...161,078,789
|
|
G |
Prkca |
protein kinase C, alpha |
|
ISO |
|
RGD |
PMID:17905752 |
RGD:2292474 |
NCBI chr11:107,824,213...108,237,360
Ensembl chr11:107,824,213...108,234,754
|
|
G |
Prss1 |
protease, serine 1 (trypsin 1) |
|
ISO |
|
RGD |
PMID:11062314 |
RGD:1599961 |
NCBI chr 6:41,435,864...41,440,720
Ensembl chr 6:41,435,866...41,440,720
|
|
G |
Ptafr |
platelet-activating factor receptor |
treatment |
IAGP ISO |
|
RGD |
PMID:12812996 PMID:11139461 |
RGD:1581279, RGD:10043168 |
NCBI chr 4:132,291,378...132,309,994
Ensembl chr 4:132,291,378...132,309,994
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19038262 PMID:17239858 |
RGD:2292538 |
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
|
|
G |
Ptges |
prostaglandin E synthase |
|
IEP ISO |
|
RGD |
PMID:16864802 PMID:12431630 |
RGD:2300094, RGD:2300116 |
NCBI chr 2:30,779,483...30,793,309
Ensembl chr 2:30,779,483...30,819,875
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10594344 PMID:16385084 |
RGD:5688223 |
NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:decreased expression:kidney CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10588920 PMID:10594344 PMID:11567657 PMID:16386242 PMID:18258783 PMID:19673871 PMID:21394482 PMID:21944479 PMID:16247333 More...
|
RGD:5135045, RGD:5508180, RGD:1580660 |
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
|
ISO |
protein:increased tyrosine phosphorylation:kidney |
RGD |
PMID:17620366 |
RGD:2292577 |
NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129
|
|
G |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
|
ISO |
protein:increased phosphorylation:hippocampus |
RGD |
PMID:15970382 |
RGD:1642621 |
NCBI chr14:66,390,706...66,518,549
Ensembl chr14:66,390,706...66,518,501
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
ISO |
protein:increased expression:nucleus, liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20302854 PMID:23743330 PMID:18621400 |
RGD:2298777 |
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
S100b |
S100 protein, beta polypeptide, neural |
|
ISO |
|
RGD |
PMID:18840784 |
RGD:5508834 |
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
|
|
G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
IDA |
|
RGD |
PMID:16403835 |
RGD:1580913 |
NCBI chr 3:115,504,082...115,508,704
Ensembl chr 3:115,504,082...115,508,721
|
|
G |
Scfd1 |
Sec1 family domain containing 1 |
|
ISO |
protein:increased expression:cerebral cortex |
RGD |
PMID:9195952 |
RGD:633771 |
NCBI chr12:51,424,296...51,496,887
Ensembl chr12:51,424,293...51,496,884
|
|
G |
Sele |
selectin, endothelial cell |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17112405 PMID:23743330 PMID:19489247 |
RGD:2313598 |
NCBI chr 1:163,867,200...163,886,056
Ensembl chr 1:163,875,773...163,885,246
|
|
G |
Sell |
selectin, lymphocyte |
|
ISO |
|
RGD |
PMID:19489247 |
RGD:2313598 |
NCBI chr 1:163,889,556...163,908,354
Ensembl chr 1:163,889,551...163,911,750
|
|
G |
Selp |
selectin, platelet |
|
ISO IEP |
|
RGD |
PMID:18521901 PMID:21701413 |
RGD:2312314, RGD:6218990 |
NCBI chr 1:163,942,833...163,977,595
Ensembl chr 1:163,942,833...163,977,595
|
|
G |
Serpine2 |
serine (or cysteine) peptidase inhibitor, clade E, member 2 |
|
ISO |
|
RGD |
PMID:8261109 |
RGD:2317936 |
NCBI chr 1:79,772,038...79,836,382
Ensembl chr 1:79,771,914...79,838,897
|
|
G |
Serping1 |
serine (or cysteine) peptidase inhibitor, clade G, member 1 |
treatment |
ISO |
|
RGD |
PMID:23991040 |
RGD:8661644 |
NCBI chr 2:84,595,704...84,605,778
Ensembl chr 2:84,595,731...84,605,788
|
|
G |
Sftpc |
surfactant associated protein C |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:20560845 |
RGD:4144062 |
NCBI chr14:70,758,381...70,761,521
Ensembl chr14:70,758,389...70,761,521
|
|
G |
Sirt7 |
sirtuin 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28675767 |
|
NCBI chr11:120,509,197...120,515,840
Ensembl chr11:120,509,198...120,516,066
|
|
G |
Sis |
sucrase isomaltase (alpha-glucosidase) |
|
ISO |
|
RGD |
PMID:9724271 |
RGD:1625550 |
NCBI chr 3:72,795,890...72,875,196
Ensembl chr 3:72,795,890...72,875,196
|
|
G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:19781384 |
RGD:2313601 |
NCBI chr 4:118,965,942...118,994,527
Ensembl chr 4:118,965,908...118,995,180
|
|
G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:19781384 |
RGD:2313601 |
NCBI chr 6:122,704,783...122,779,149
Ensembl chr 6:122,704,768...122,778,599
|
|
G |
Slc30a4 |
solute carrier family 30 (zinc transporter), member 4 |
|
ISO |
mRNA:increased expression:brain |
RGD |
PMID:18289514 |
RGD:2299950 |
NCBI chr 2:122,523,153...122,544,583
Ensembl chr 2:122,523,153...122,544,583
|
|
G |
Slc34a1 |
solute carrier family 34 (sodium phosphate), member 1 |
|
ISO |
protein:decreased expression:renal proximal tubule |
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chr13:55,547,435...55,562,508
Ensembl chr13:55,546,000...55,563,405
|
|
G |
Slc6a11 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 11 |
|
ISO |
|
RGD |
PMID:13678673 |
RGD:1299345 |
NCBI chr 6:114,108,202...114,226,847
Ensembl chr 6:114,108,202...114,226,913
|
|
G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
ISO |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chr17:81,680,534...82,045,816
Ensembl chr17:81,680,534...82,045,806
|
|
G |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
|
ISO |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chr 7:15,861,540...15,894,988
Ensembl chr 7:15,863,751...15,894,988
|
|
G |
Slc8a3 |
solute carrier family 8 (sodium/calcium exchanger), member 3 |
|
ISO |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chr12:81,244,689...81,380,506
Ensembl chr12:81,244,689...81,379,954
|
|
G |
Slc9a1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:19027022 PMID:20337040 |
RGD:6771332 |
NCBI chr 4:133,097,022...133,151,013
Ensembl chr 4:133,097,017...133,151,013
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family, member 1b2 |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:16858290 |
RGD:2303111 |
NCBI chr 6:141,575,178...141,632,372
Ensembl chr 6:141,575,244...141,632,372
|
|
G |
Slk |
STE20-like kinase |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:12965890 |
RGD:2304069 |
NCBI chr19:47,568,458...47,633,685
Ensembl chr19:47,568,117...47,633,685
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8215636 |
|
NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
ISO |
associated with Brain Ischemia;mRNA, protein:increased expression:cerebral cortex |
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873
|
|
G |
Socs4 |
suppressor of cytokine signaling 4 |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr14:47,514,377...47,533,559
Ensembl chr14:47,514,388...47,533,559
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
|
IDA ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:15364863 PMID:16397181 PMID:23061969 PMID:23743330 PMID:15364863 |
RGD:1580834 |
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:8215636 PMID:16682413 PMID:19193722 PMID:19917352 PMID:21940958 PMID:23743330 PMID:15612529 PMID:15087276 More...
|
RGD:1582141, RGD:1581259 |
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
|
|
G |
Sod3 |
superoxide dismutase 3, extracellular |
|
IDA |
|
RGD |
PMID:15778274 |
RGD:1581264 |
NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
IAGP |
|
RGD |
PMID:20548025 |
RGD:6903275 |
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
|
|
G |
Src |
Rous sarcoma oncogene |
|
ISO |
protein:increased phosphorylation:hippocampus CA1 (rat) |
RGD |
PMID:20197063 |
RGD:2325012 |
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
ISO |
protein:increased serine phosphorylation:brain protein:increased phosphorylation:kidney |
RGD |
PMID:15262323 PMID:17670769 |
RGD:1600103, RGD:2291900 |
NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr10:128,106,367...128,128,722
Ensembl chr10:128,106,428...128,128,718
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr11:100,750,177...100,775,995
Ensembl chr11:100,750,177...100,775,995
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr11:100,671,557...100,741,407
Ensembl chr11:100,671,557...100,741,550
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826
|
|
G |
Stc1 |
stanniocalcin 1 |
|
ISO |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:15485913 |
RGD:2324700 |
NCBI chr14:69,266,738...69,278,850
Ensembl chr14:69,266,687...69,279,253
|
|
G |
Stc2 |
stanniocalcin 2 |
|
ISO |
mRNA, protein:increased expression:cerebral cortex |
RGD |
PMID:15485913 |
RGD:2324700 |
NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074
|
|
G |
Sult1e1 |
sulfotransferase family 1E, member 1 |
|
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25922074 PMID:16908442 |
RGD:2302564 |
NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453
|
|
G |
Tbxas1 |
thromboxane A synthase 1, platelet |
|
ISO |
associated with Cholestasis, Extrahepatic |
RGD |
PMID:8680115 PMID:15000260 |
RGD:1601451 RGD:1601475 |
NCBI chr 6:38,817,897...39,061,524
Ensembl chr 6:38,852,338...39,061,519
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16968891 |
|
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
|
|
G |
Tfam |
transcription factor A, mitochondrial |
|
ISO |
|
RGD |
PMID:22266265 |
RGD:6767573 |
NCBI chr10:71,061,298...71,074,157
Ensembl chr10:71,061,294...71,074,110
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
ISO |
|
RGD |
PMID:15613744 |
RGD:1579926 |
NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428
|
|
G |
Th |
tyrosine hydroxylase |
|
ISO |
protein:increased expression:medulla oblongata (human) |
RGD |
PMID:21061149 |
RGD:5128821 |
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
|
|
G |
Thbd |
thrombomodulin |
|
IDA |
|
RGD |
PMID:19342415 |
RGD:5131887 |
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
|
|
G |
Thbs1 |
thrombospondin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614
|
|
G |
Thy1 |
thymus cell antigen 1, theta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chr 9:43,954,681...43,959,876
Ensembl chr 9:43,954,681...43,959,876
|
|
G |
Ticam1 |
TIR domain containing adaptor molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25780291 |
|
NCBI chr17:56,576,462...56,583,767
Ensembl chr17:56,576,319...56,583,786
|
|
G |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
|
ISO |
protein:decreased expression:brain |
RGD |
PMID:17551674 |
RGD:2290424 |
NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370
|
|
G |
Tjp1 |
tight junction protein 1 |
|
ISO |
protein:decreased expression:brain, endothelial cell |
RGD |
PMID:19374856 PMID:19929946 |
RGD:2325135, RGD:2325127 |
NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
mRNA, protein:increased expression:kidney CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25780291 PMID:15912106 |
RGD:2312727 |
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
|
|
G |
Tlr3 |
toll-like receptor 3 |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:21355876 |
RGD:5128693 |
NCBI chr 8:45,848,702...45,864,112
Ensembl chr 8:45,848,702...45,864,117
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO IMP |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25780291 PMID:27064547 PMID:19473433 PMID:17126102 |
RGD:2312503, RGD:4144169 |
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tmbim6 |
transmembrane BAX inhibitor motif containing 6 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:18005084 |
RGD:2291961 |
NCBI chr15:99,290,828...99,307,930
Ensembl chr15:99,290,763...99,307,930
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10706834 PMID:12024109 PMID:15829914 PMID:16971220 PMID:17112405 PMID:18460982 PMID:19058328 PMID:23743330 PMID:23875703 PMID:24898700 More...
|
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
ISO |
|
RGD |
PMID:17109621 |
RGD:1624182 |
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
G |
Trp53 |
transformation related protein 53 |
|
ISO |
protein:increased expression:brain, mitochondrion |
RGD |
PMID:17661174 |
RGD:2290568 |
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
treatment |
ISO |
|
RGD |
PMID:20554625 |
RGD:4891135 |
NCBI chr 9:8,543,868...8,680,753
Ensembl chr 9:8,544,143...8,680,742
|
|
G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
|
ISO |
mRNA,protein:increased expression:hippocampus |
RGD |
PMID:18395621 |
RGD:5684390 |
NCBI chr 2:126,633,478...126,718,181
Ensembl chr 2:126,633,485...126,718,150
|
|
G |
Try10 |
trypsin 10 |
|
ISO |
|
RGD |
PMID:11062314 |
RGD:1599961 |
NCBI chr 6:41,331,039...41,334,878
Ensembl chr 6:41,331,039...41,334,848
|
|
G |
Txn1 |
thioredoxin 1 |
|
ISO |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
|
|
G |
Txn2 |
thioredoxin 2 |
|
ISO |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chr15:77,799,251...77,813,194
Ensembl chr15:77,799,247...77,813,206
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
|
ISO |
mRNA:decreased expression:cerebral cortex mRNA:decreased expression:spinal cord |
RGD |
PMID:19128823 PMID:19409971 |
RGD:5685030, RGD:5685028 |
NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
|
ISO |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chr16:18,245,167...18,297,823
Ensembl chr16:18,245,134...18,297,823
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:18813897 |
RGD:2313108 |
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
|
|
G |
Vegfc |
vascular endothelial growth factor C |
|
ISO |
|
RGD |
PMID:18704465 |
RGD:2315487 |
NCBI chr 8:54,530,567...54,639,489
Ensembl chr 8:54,530,641...54,640,131
|
|
G |
Vegfd |
vascular endothelial growth factor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr X:163,156,282...163,185,643
Ensembl chr X:163,156,374...163,185,646
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
|
|
G |
Vip |
vasoactive intestinal polypeptide |
|
IDA |
|
RGD |
PMID:21693218 |
RGD:5685379 |
NCBI chr10:5,589,131...5,597,617
Ensembl chr10:5,589,218...5,597,617
|
|
G |
Wnt3a |
wingless-type MMTV integration site family, member 3A |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23875703 |
|
NCBI chr11:59,138,859...59,181,579
Ensembl chr11:59,138,859...59,181,578
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12910483 PMID:23403765 |
RGD:7247700 |
NCBI chr17:74,190,890...74,257,369
Ensembl chr17:74,190,890...74,257,191
|
|
G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865
|
|
G |
Zfp354a |
zinc finger protein 354A |
|
ISO |
mRNA:decreased expression:kidney |
RGD |
PMID:8382778 |
RGD:1300202 |
NCBI chr11:50,950,052...50,963,626
Ensembl chr11:50,950,084...50,963,626
|
|
|
G |
F3 |
coagulation factor III |
|
ISO |
|
RGD |
PMID:9916935 |
RGD:11341701 |
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
|
|
G |
Hnrnpk |
heterogeneous nuclear ribonucleoprotein K |
|
ISO |
|
RGD |
PMID:21489814 |
RGD:155260371 |
NCBI chr13:58,538,946...58,551,157
Ensembl chr13:58,538,956...58,551,157
|
|
G |
Pdgfd |
platelet-derived growth factor, D polypeptide |
|
ISO |
|
RGD |
PMID:19213942 |
RGD:9854642 |
NCBI chr 9:6,168,377...6,534,284
Ensembl chr 9:6,168,584...6,378,850
|
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
treatment |
ISO |
|
RGD |
PMID:22217518 PMID:23769041 |
RGD:7245568, RGD:8695995 |
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
|
|
G |
C3 |
complement component 3 |
treatment |
ISO |
|
RGD |
PMID:25122638 |
RGD:11040803 |
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
Cd40 |
CD40 antigen |
treatment |
ISO |
|
RGD |
PMID:22826618 |
RGD:11352297 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
ISO |
liver |
RGD |
PMID:22826618 |
RGD:11352297 |
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
|
|
G |
F7 |
coagulation factor VII |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:12095034 |
RGD:11049508 |
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
|
RGD |
PMID:22217518 |
RGD:7245568 |
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
treatment |
ISO |
|
RGD |
PMID:23985719 |
RGD:10041002 |
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
|
RGD |
PMID:24598936 |
RGD:10450586 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
|
G |
Aco1 |
aconitase 1 |
|
ISO |
|
RGD |
PMID:20176611 |
RGD:11541086 |
NCBI chr 4:40,143,265...40,199,009
Ensembl chr 4:40,143,081...40,198,338
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:24370342 |
RGD:11035281 |
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
ISO |
|
RGD |
PMID:17298994 |
RGD:7241819 |
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
|
|
G |
Ccn2 |
cellular communication network factor 2 |
disease_progression |
ISO |
mRNA, protein:increased expression:kidney (rat) |
RGD |
PMID:19921985 |
RGD:150517553 |
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
|
|
G |
Clu |
clusterin |
treatment |
ISO |
|
RGD |
PMID:22494435 |
RGD:9068431 |
NCBI chr14:66,205,932...66,218,997
Ensembl chr14:66,205,932...66,218,996
|
|
G |
Cs |
citrate synthase |
treatment |
ISO |
|
RGD |
PMID:20005400 |
RGD:243048470 |
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
|
ISO |
|
RGD |
PMID:22845765 |
RGD:7241226 |
NCBI chr 9:7,445,822...7,455,975
Ensembl chr 9:7,445,822...7,455,975
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
treatment |
ISO |
|
RGD |
PMID:18209025 |
RGD:9685339 |
NCBI chr 9:7,692,091...7,699,586
Ensembl chr 9:7,692,091...7,699,586
|
|
G |
Pdgfa |
platelet derived growth factor, alpha |
|
ISO |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chr 5:138,961,769...138,986,336
Ensembl chr 5:138,961,769...138,983,125
|
|
G |
Pdgfb |
platelet derived growth factor, B polypeptide |
|
ISO |
mRNA:increased expression:kidney: |
RGD |
PMID:15785371 PMID:11889420 |
RGD:10449491, RGD:11080974 |
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
|
|
G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
ISO |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
|
|
G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
ISO |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
protein:increased secretion:T lymphocyte (human) |
RGD |
PMID:16387096 |
RGD:7241259 |
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
protein:increased expression:kidney: |
RGD |
PMID:16221712 |
RGD:13208600 |
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
treatment |
ISO |
protein:increased expression:kidney: |
RGD |
PMID:16221712 PMID:18192922 |
RGD:13208600, RGD:13208601 |
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:22305384 |
RGD:10395369 |
NCBI chr17:87,061,292...87,140,838
Ensembl chr17:87,061,128...87,140,838
|
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
|
ISO |
mRNA,protein:decreased expression:stomach: |
RGD |
PMID:20040059 |
RGD:12911222 |
NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382
|
|
G |
Kitl |
kit ligand |
|
ISO |
mRNA:decreased expression:stomach: |
RGD |
PMID:20040059 |
RGD:12911222 |
NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
|
|
|
G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
ISO |
|
RGD |
PMID:15001561 |
RGD:13515113 |
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
|
|
G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:15001561 |
RGD:13515113 |
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
treatment |
ISO |
|
RGD |
PMID:24232000 |
RGD:13792678 |
NCBI chr10:79,974,451...79,981,662
Ensembl chr10:79,974,466...79,981,652
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:23946597 |
RGD:13782356 |
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:23946597 |
RGD:13782356 |
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
ISO |
mRNA:increased expression:small intestine |
RGD |
PMID:18475188 |
RGD:2307016 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Cd14 |
CD14 antigen |
|
ISO |
protein:increased expression:heart, kidney, liver, lung |
RGD |
PMID:22493902 |
RGD:9685194 |
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
|
|
G |
Cldn1 |
claudin 1 |
|
ISO |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591
|
|
G |
Cldn3 |
claudin 3 |
|
ISO |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chr 5:135,015,068...135,016,330
Ensembl chr 5:135,015,068...135,016,326
|
|
G |
Cldn5 |
claudin 5 |
|
ISO |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chr16:18,595,597...18,597,012
Ensembl chr16:18,595,597...18,597,012
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
|
ISO |
protein:increased expression:intestine: |
RGD |
PMID:17981193 |
RGD:5129536 |
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
|
|
G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
treatment |
ISO |
|
RGD |
PMID:9117128 |
RGD:11039476 |
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
F7 |
coagulation factor VII |
|
ISO |
human protein in a rat model |
RGD |
PMID:22920553 |
RGD:11041662 |
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
|
|
G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
treatment |
ISO |
|
RGD |
PMID:29170412 |
RGD:13792603 |
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
|
RGD |
PMID:22093738 |
RGD:10402181 |
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:19362701 |
RGD:10766423 |
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hp |
haptoglobin |
treatment |
ISO |
|
RGD |
PMID:11922743 |
RGD:11041790 |
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:12095141 |
RGD:11522715 |
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Il6 |
interleukin 6 |
treatment |
ISO |
|
RGD |
PMID:11959089 |
RGD:11062110 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
|
RGD |
PMID:22777122 |
RGD:10403072 |
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
ISO |
protein:increased expression:heart, kidney, liver, lung |
RGD |
PMID:22493902 |
RGD:9685194 |
NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
severity |
ISO |
DNA:polymorphisms:exon: |
RGD |
PMID:19477015 |
RGD:12910933 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
Mir155 |
microRNA 155 |
|
IEP |
miRNA:increased expression:Peyer's patch |
RGD |
PMID:30206757 |
RGD:21409753 |
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
|
|
G |
Mir21a |
microRNA 21a |
|
ISO |
|
RGD |
PMID:30309483 |
RGD:41410822 |
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
treatment |
ISO |
|
RGD |
PMID:16610051 |
RGD:7777112 |
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
treatment |
ISO |
|
RGD |
PMID:28382390 |
RGD:13440093 |
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
disease_progression |
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:23331901 |
RGD:15042883 |
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
|
|
G |
Parg |
poly (ADP-ribose) glycohydrolase |
treatment |
IMP |
|
RGD |
PMID:15791006 |
RGD:13514040 |
NCBI chr14:31,923,900...32,020,671
Ensembl chr14:31,923,906...32,019,507
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
ISO |
mRNA:increased expression:jejunum (human) |
RGD |
PMID:20965186 |
RGD:9999150 |
NCBI chr 7:45,172,341...45,175,692
Ensembl chr 7:45,172,340...45,175,692
|
|
G |
Proc |
protein C |
treatment |
ISO |
|
RGD |
PMID:15187522 |
RGD:11250409 |
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
|
|
G |
Serpinc1 |
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
treatment |
ISO |
|
RGD |
PMID:21046505 |
RGD:11035258 |
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
|
ISO |
protein:increased activity:plasma (rat) |
RGD |
PMID:12717359 |
RGD:11081012 |
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
treatment |
ISO |
|
RGD |
PMID:27538408 |
RGD:151347179 |
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
|
|
G |
Traf6 |
TNF receptor-associated factor 6 |
|
ISO |
|
RGD |
PMID:27538408 |
RGD:151347179 |
NCBI chr 2:101,508,765...101,532,013
Ensembl chr 2:101,508,774...101,532,014
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
ameliorates |
ISO |
associated with mesenteric vascular occlusion; |
RGD |
PMID:18091551 |
RGD:127284848 |
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
|
|
G |
Vwf |
Von Willebrand factor |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:10365842 |
RGD:11080742 |
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
ISO |
|
RGD |
PMID:23010742 |
RGD:13209016 |
NCBI chr17:74,190,890...74,257,369
Ensembl chr17:74,190,890...74,257,191
|
|
|
G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
ISO |
|
RGD |
PMID:21680852 |
RGD:6893484 |
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
|
|
G |
Ace2 |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
|
ISO |
mRNA:decreased expression:kidney |
RGD |
PMID:20528771 |
RGD:9685432 |
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
|
|
G |
Acvr2b |
activin receptor IIB |
treatment |
ISO |
human construct in rat model |
RGD |
PMID:27732750 |
RGD:329322881 |
NCBI chr 9:119,231,081...119,271,214
Ensembl chr 9:119,231,184...119,264,061
|
|
G |
Adam17 |
a disintegrin and metallopeptidase domain 17 |
treatment |
ISO |
|
RGD |
PMID:22015440 |
RGD:13703100 |
NCBI chr12:21,373,510...21,423,633
Ensembl chr12:21,373,510...21,423,633
|
|
G |
Adam2 |
a disintegrin and metallopeptidase domain 2 |
|
ISO |
|
RGD |
PMID:11967014 |
RGD:10047130 |
NCBI chr14:66,264,771...66,315,300
Ensembl chr14:66,264,778...66,315,182
|
|
G |
Adamts1 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 |
|
ISO |
|
RGD |
PMID:18272597 |
RGD:9684850 |
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
ISO |
|
RGD |
PMID:21412771 |
RGD:8695946 |
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
|
|
G |
Adm |
adrenomedullin |
treatment |
ISO |
protein:increased expression:serum: |
RGD |
PMID:20538296 PMID:20538296 |
RGD:7364948, RGD:7364948 |
NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027
|
|
G |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
IMP |
|
RGD |
PMID:31089212 |
RGD:27226686 |
NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
IMP |
|
RGD |
PMID:22022451 |
RGD:7241603 |
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
|
|
G |
Anxa1 |
annexin A1 |
treatment |
ISO |
|
RGD |
PMID:20953576 |
RGD:7421585 |
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
|
|
G |
Anxa5 |
annexin A5 |
|
ISO |
|
RGD |
PMID:21918686 |
RGD:7242028 |
NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
treatment |
ISO |
|
RGD |
PMID:26362957 |
RGD:13703110 |
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
Apoa1 |
apolipoprotein A-I |
treatment |
ISO |
|
RGD |
PMID:18535924 |
RGD:7241574 |
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
|
|
G |
Atm |
ataxia telangiectasia mutated |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:22768306 |
RGD:10053607 |
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
|
|
G |
Bax |
BCL2-associated X protein |
treatment |
ISO |
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
treatment |
ISO |
|
RGD |
PMID:18221257 PMID:29285062 |
RGD:2293026, RGD:13792599 |
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bdkrb1 |
bradykinin receptor, beta 1 |
|
IMP |
|
RGD |
PMID:18725957 |
RGD:7241559 |
NCBI chr12:105,570,350...105,571,770
Ensembl chr12:105,569,344...105,571,687
|
|
G |
Becn1 |
beclin 1, autophagy related |
treatment |
ISO |
|
RGD |
PMID:26412257 |
RGD:11561958 |
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
|
|
G |
Bmi1 |
Bmi1 polycomb ring finger oncogene |
|
IEP |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr 2:18,681,953...18,691,440
Ensembl chr 2:18,681,829...18,691,440
|
|
G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:23698117 |
RGD:11561968 |
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
|
|
G |
C3 |
complement component 3 |
treatment |
ISO |
|
RGD |
PMID:19691975 |
RGD:7411689 |
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
Calca |
calcitonin/calcitonin-related polypeptide, alpha |
|
ISO |
|
RGD |
PMID:19194162 |
RGD:7204479 |
NCBI chr 7:114,225,223...114,236,145
Ensembl chr 7:114,230,713...114,235,592
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp7 |
caspase 7 |
|
ISO |
|
RGD |
PMID:17596683 |
RGD:5684536 |
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
treatment |
IDA |
|
RGD |
PMID:22160777 |
RGD:7247742 |
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
|
|
G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
treatment |
IEP ISO |
mRNA, protein:increased expression:kidney, lung, serum |
RGD |
PMID:20396927 PMID:18650485 |
RGD:4891433, RGD:11526113 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Cd14 |
CD14 antigen |
|
IEP |
mRNA,protein:increased expression:kidney |
RGD |
PMID:10966493 |
RGD:7204444 |
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
|
|
G |
Cd40 |
CD40 antigen |
treatment |
ISO |
|
RGD |
PMID:25993320 |
RGD:11251055 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cfb |
complement factor B |
|
IMP |
|
RGD |
PMID:16467447 PMID:12538716 |
RGD:7242709, RGD:7242734 |
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
|
|
G |
Cfh |
complement component factor h |
treatment |
ISO |
protein:decreased expression:serum: |
RGD |
PMID:20538296 PMID:20538296 |
RGD:7364948, RGD:7364948 |
NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
|
|
G |
Ciita |
class II transactivator |
|
IEP |
|
RGD |
PMID:14569092 |
RGD:7242896 |
NCBI chr16:10,297,877...10,348,928
Ensembl chr16:10,297,923...10,346,282
|
|
G |
Cited1 |
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
|
IEP |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr X:101,290,984...101,295,787
Ensembl chr X:101,290,987...101,295,787
|
|
G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
IMP ISO |
mRNA:increased expression:kidney |
RGD |
PMID:23143303 PMID:19196448 |
RGD:7257565, RGD:7257570 |
NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
IMP |
|
RGD |
PMID:23143303 |
RGD:7257565 |
NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
IMP ISO |
|
RGD |
PMID:22189844 PMID:9407517 |
RGD:7204675, RGD:7204727 |
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
|
|
G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
IMP |
|
RGD |
PMID:20038794 |
RGD:7257679 |
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,148...74,200,405
|
|
G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:29073721 |
RGD:13825150 |
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
treatment |
ISO |
|
RGD |
PMID:23552495 |
RGD:7244372 |
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
|
|
G |
Daxx |
Fas death domain-associated protein |
|
IEP ISO |
protein:increased expression:kidney: |
RGD |
PMID:18480747 PMID:18480747 |
RGD:9587836, RGD:9587836 |
NCBI chr17:34,128,379...34,134,564
Ensembl chr17:34,128,388...34,134,564
|
|
G |
Ddr1 |
discoidin domain receptor family, member 1 |
|
IEP |
protein:increased expression:kidney (mouse) |
RGD |
PMID:31383731 |
RGD:151347540 |
NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
|
|
G |
Dhfr |
dihydrofolate reductase |
|
ISO |
mRNA,protein:decreased expression:kidney: |
RGD |
PMID:18408363 |
RGD:11040540 |
NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
|
|
G |
Drd3 |
dopamine receptor D3 |
treatment |
ISO |
|
RGD |
PMID:25989500 |
RGD:13506961 |
NCBI chr16:43,574,285...43,646,353
Ensembl chr16:43,574,389...43,643,295
|
|
G |
Eed |
embryonic ectoderm development |
|
IEP |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr 7:89,603,862...89,630,184
Ensembl chr 7:89,603,862...89,630,191
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
|
ISO |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chr 8:125,635,325...125,676,063
Ensembl chr 8:125,635,326...125,676,063
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
|
ISO |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chr12:54,225,767...54,250,660
Ensembl chr12:54,225,767...54,250,646
|
|
G |
Elane |
elastase, neutrophil expressed |
treatment |
ISO |
|
RGD |
PMID:16980042 |
RGD:10450580 |
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
|
|
G |
Eng |
endoglin |
|
ISO IMP |
mRNA, protein:increased expression:kidney (rat) |
RGD |
PMID:16751653 PMID:16751653 |
RGD:7248779, RGD:7248779 |
NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
protein:altered localization:kidney (rat) |
RGD |
PMID:23936185 |
RGD:7257563 |
NCBI chr15:81,470,329...81,536,278
Ensembl chr15:81,469,552...81,536,278
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:19961832 PMID:25581532 |
RGD:10401077, RGD:11041698 |
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
|
IEP |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
|
|
G |
F3 |
coagulation factor III |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:25883098 |
RGD:11341735 |
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
|
|
G |
Fas |
Fas (TNF receptor superfamily member 6) |
treatment |
ISO |
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
treatment |
ISO |
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
|
|
G |
Fcgr1 |
Fc receptor, IgG, high affinity I |
treatment |
ISO |
|
RGD |
PMID:22402584 |
RGD:9685699 |
NCBI chr 3:96,190,225...96,201,285
Ensembl chr 3:96,190,225...96,201,285
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
|
|
G |
Fgb |
fibrinogen beta chain |
treatment |
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:21685370 PMID:21685370 |
RGD:7175292, RGD:7175292 |
NCBI chr 3:82,949,553...82,957,170
Ensembl chr 3:82,947,448...82,957,170
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
exacerbates ameliorates |
IEP ISO IMP |
protein:increased phosphorylation:kidney (mouse) |
RGD |
PMID:20591940 PMID:22688984 PMID:29344510 PMID:32523960 |
RGD:155663667, RGD:155882537, RGD:155782904, RGD:155782882 |
NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079
|
|
G |
Fgg |
fibrinogen gamma chain |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chr 3:82,915,031...82,922,363
Ensembl chr 3:82,915,031...82,922,356
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
|
RGD |
PMID:11352844 |
RGD:7205629 |
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
|
IEP |
|
RGD |
PMID:19095962 |
RGD:7242184 |
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
protein:increased expression:kidney: |
RGD |
PMID:20332418 PMID:20332418 |
RGD:9685723, RGD:9685723 |
NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,130
|
|
G |
Glo1 |
glyoxalase 1 |
|
ISO |
|
RGD |
PMID:19211689 PMID:19211689 |
RGD:7242566, RGD:7242566 |
NCBI chr17:30,811,835...30,831,633
Ensembl chr17:30,803,910...30,845,845
|
|
G |
Gsr |
glutathione reductase |
treatment |
ISO |
|
RGD |
PMID:24630969 |
RGD:10401866 |
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gstm1 |
glutathione S-transferase, mu 1 |
|
ISO |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:29137244 |
RGD:158014894 |
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
|
|
G |
H2ax |
H2A.X variant histone |
treatment |
ISO |
|
RGD |
PMID:23726287 |
RGD:8693706 |
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
|
|
G |
Has1 |
hyaluronan synthase 1 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr17:18,063,588...18,075,450
Ensembl chr17:18,063,585...18,075,467
|
|
G |
Has2 |
hyaluronan synthase 2 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr15:56,529,023...56,557,942
Ensembl chr15:56,529,023...56,557,935
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO IEP |
protein:increased expression:urine: |
RGD |
PMID:23552495 PMID:23019274 PMID:23085062 |
RGD:7244372, RGD:7245495, RGD:7245489 |
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
|
|
G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
treatment severity |
ISO |
|
RGD |
PMID:17519789 PMID:22432008 |
RGD:1626334, RGD:9068883 |
NCBI chr12:73,948,098...73,994,328
Ensembl chr12:73,948,149...73,994,304
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:21291499 |
RGD:10755580 |
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hsf1 |
heat shock factor 1 |
|
ISO |
protein:increased expression:kidney (rat) |
RGD |
PMID:23102208 |
RGD:10402775 |
NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
|
|
G |
Hspa8 |
heat shock protein 8 |
|
ISO |
|
RGD |
PMID:7569112 |
RGD:7242788 |
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
|
|
G |
Hyal1 |
hyaluronoglucosaminidase 1 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 9:107,454,149...107,458,898
Ensembl chr 9:107,454,126...107,458,909
|
|
G |
Hyal2 |
hyaluronoglucosaminidase 2 |
|
ISO |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 9:107,445,096...107,449,975
Ensembl chr 9:107,445,144...107,449,978
|
|
G |
Ifng |
interferon gamma |
treatment |
IEP |
|
RGD |
PMID:28355607 |
RGD:14975115 |
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Igf1r |
insulin-like growth factor I receptor |
|
ISO |
mRNA: increased expression: kidney: 3 and 5 days post ischemia |
RGD |
PMID:10990448 |
RGD:7242905 |
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
|
|
G |
Ikbkb |
inhibitor of kappaB kinase beta |
treatment |
ISO |
|
RGD |
PMID:19546526 |
RGD:7495779 |
NCBI chr 8:23,149,221...23,196,605
Ensembl chr 8:23,149,228...23,196,605
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO IEP |
|
RGD |
PMID:24079335 PMID:28664613 |
RGD:7364864, RGD:14975137 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il18 |
interleukin 18 |
treatment |
ISO |
|
RGD |
PMID:22089199 |
RGD:8655971 |
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
|
RGD |
PMID:20030532 |
RGD:7175501 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO IMP |
rat model treated with human protein mouse model treated with human protein |
RGD |
PMID:18363573 PMID:9555664 PMID:16849996 |
RGD:6907101, RGD:6909149, RGD:6907359 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Inhbb |
inhibin beta-B |
|
ISO |
protein:increased expression:serum (rat) |
RGD |
PMID:27732750 |
RGD:329322881 |
NCBI chr 1:119,343,193...119,349,978
Ensembl chr 1:119,343,195...119,349,978
|
|
G |
Itgb2 |
integrin beta 2 |
|
ISO |
Associated with renal transplant patients |
RGD |
PMID:20504838 PMID:11007822 |
RGD:6907049, RGD:6907073 |
NCBI chr10:77,366,164...77,401,542
Ensembl chr10:77,366,086...77,401,542
|
|
G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
ISO |
protein:decreased expression:kidney |
RGD |
PMID:21250976 |
RGD:7297045 |
NCBI chr 7:45,746,545...45,750,215
Ensembl chr 7:45,743,377...45,750,188
|
|
G |
Kl |
klotho |
treatment |
ISO IMP |
mRNA,protein:decreased expression:renal tubule: |
RGD |
PMID:16204278 PMID:16204278 |
RGD:10403064, RGD:10403064 |
NCBI chr 5:150,876,072...150,917,282
Ensembl chr 5:150,876,072...150,917,282
|
|
G |
Kmt2a |
lysine (K)-specific methyltransferase 2A |
|
IEP |
protein:increased expression:kidney (mouse) |
RGD |
PMID:31570196 |
RGD:155888490 |
NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO IEP |
protein:increased expression:urine: mRNA,protein:increased expression:kidney,urine mRNA,protein:increased expression:kidney: |
RGD |
PMID:23364806 PMID:27800610 PMID:20181666 PMID:23085062 |
RGD:7245469, RGD:126790572, RGD:126779563, RGD:7245489 |
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
|
|
G |
Lep |
leptin |
resistance |
ISO |
|
RGD |
PMID:22969992 |
RGD:6909133 |
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
|
|
G |
Lgals3 |
lectin, galactose binding, soluble 3 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:10980121 |
RGD:9685228 |
NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
treatment |
IEP ISO |
|
RGD |
PMID:20075199 PMID:26412257 |
RGD:11561916, RGD:11561958 |
NCBI chr 2:155,118,284...155,119,993
Ensembl chr 2:155,118,217...155,119,993
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
treatment |
ISO |
|
RGD |
PMID:23952292 |
RGD:10412647 |
NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499
|
|
G |
Mc1r |
melanocortin 1 receptor |
|
ISO |
protein:decreased expression:kidney outer medulla |
RGD |
PMID:18790174 |
RGD:5687322 |
NCBI chr 8:124,133,839...124,137,483
Ensembl chr 8:124,133,846...124,137,483
|
|
G |
Mir146 |
microRNA 146 |
treatment |
ISO |
|
RGD |
PMID:27760486 |
RGD:155882556 |
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
|
|
G |
Mir320 |
microRNA 320 |
treatment |
ISO |
|
RGD |
PMID:31089916 PMID:27760486 |
RGD:155882543, RGD:155882556 |
NCBI chr14:70,680,950...70,681,031
Ensembl chr14:70,680,950...70,681,031
|
|
G |
Mir381 |
microRNA 381 |
|
ISO |
RNA:decreased expression:kidney |
RGD |
PMID:29073721 |
RGD:13825150 |
NCBI chr12:109,693,256...109,693,330
Ensembl chr12:109,693,256...109,693,330
|
|
G |
Mir423 |
microRNA 423 |
treatment |
ISO |
|
RGD |
PMID:29137244 |
RGD:158014894 |
NCBI chr11:76,968,890...76,968,998
Ensembl chr11:76,968,890...76,968,998
|
|
G |
Mir494 |
microRNA 494 |
ameliorates |
IMP |
|
RGD |
PMID:23160513 |
RGD:155883172 |
NCBI chr12:109,681,752...109,681,836
Ensembl chr12:109,681,752...109,681,836
|
|
G |
Mpo |
myeloperoxidase |
|
ISO IMP |
protein:increased activity:kidney |
RGD |
PMID:22950848 PMID:18055546 |
RGD:6909167, RGD:7174699 |
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Muc1 |
mucin 1, transmembrane |
treatment |
ISO |
|
RGD |
PMID:22019164 |
RGD:7245959 |
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
|
|
G |
Myc |
myelocytomatosis oncogene |
|
ISO |
mRNA:increased expression:kidney (rat) |
RGD |
PMID:17220792 |
RGD:7207777 |
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Ndufb8 |
NADH:ubiquinone oxidoreductase subunit B8 |
|
ISO IEP |
|
RGD |
PMID:24096033 PMID:22160772 |
RGD:13801197, RGD:13801199 |
NCBI chr19:44,537,010...44,543,881
Ensembl chr19:44,537,011...44,543,879
|
|
G |
Nes |
nestin |
|
ISO |
|
RGD |
PMID:24503548 |
RGD:11570523 |
NCBI chr 3:87,878,400...87,887,758
Ensembl chr 3:87,878,385...87,887,758
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
treatment |
ISO |
|
RGD |
PMID:31089916 |
RGD:155882543 |
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
treatment |
ISO |
|
RGD |
PMID:29291552 |
RGD:13504682 |
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Nppa |
natriuretic peptide type A |
|
ISO |
|
RGD |
PMID:20471588 |
RGD:7247717 |
NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
treatment |
ISO |
|
RGD |
PMID:21545725 |
RGD:11035217 |
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
severity |
IEP IMP |
mRNA:increased expression:kidney |
RGD |
PMID:22343121 PMID:22343121 |
RGD:14700869, RGD:14700869 |
NCBI chr15:101,151,783...101,172,676
Ensembl chr15:101,152,150...101,172,676
|
|
G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
|
ISO |
|
RGD |
PMID:12531391 |
RGD:2317150 |
NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029
|
|
G |
Pax2 |
paired box 2 |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:12444203 |
RGD:727468 |
NCBI chr19:44,735,040...44,826,708
Ensembl chr19:44,744,484...44,826,310
|
|
G |
Pdgfb |
platelet derived growth factor, B polypeptide |
|
ISO |
mRNA,protein:increased expression:tubule, S3 segment: |
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
|
|
G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
|
|
G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:12819032 PMID:10550325 |
RGD:1580850, RGD:8554477 |
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
|
|
G |
Pkd2 |
polycystin 2, transient receptor potential cation channel |
|
ISO |
protein:increased expression:kidney (rat) |
RGD |
PMID:12454224 |
RGD:1580868 |
NCBI chr 5:104,599,379...104,653,685
Ensembl chr 5:104,607,316...104,653,685
|
|
G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
treatment |
ISO |
|
RGD |
PMID:24918615 |
RGD:10059636 |
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
|
|
G |
Rnls |
renalase, FAD-dependent amine oxidase |
|
ISO IMP IEP |
mRNA,protein:decreased expression:kidney,plasma: |
RGD |
PMID:23393318 PMID:23393318 PMID:23393318 |
RGD:7327166, RGD:7327166, RGD:7327166 |
NCBI chr19:33,115,140...33,369,695
Ensembl chr19:33,115,147...33,369,665
|
|
G |
Serpinc1 |
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
severity |
ISO |
|
RGD |
PMID:26108065 PMID:26108065 |
RGD:11354006, RGD:11354006 |
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
|
|
G |
Shh |
sonic hedgehog |
|
IEP |
mRNA, protein:increased expression:kidney |
RGD |
PMID:24744439 |
RGD:12859042 |
NCBI chr 5:28,661,838...28,672,099
Ensembl chr 5:28,661,813...28,672,254
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
ISO |
|
RGD |
PMID:22324445 |
RGD:9495930 |
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
|
|
G |
Six2 |
sine oculis-related homeobox 2 |
|
IEP |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr17:85,970,276...85,995,682
Ensembl chr17:85,991,705...85,995,702
|
|
G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
ISO |
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
ISO |
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
|
|
G |
Slc34a1 |
solute carrier family 34 (sodium phosphate), member 1 |
|
ISO |
protein:decreased expression:renal proximal tubule, brush border membrane (rat) |
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chr13:55,547,435...55,562,508
Ensembl chr13:55,546,000...55,563,405
|
|
G |
Src |
Rous sarcoma oncogene |
|
ISO |
|
RGD |
PMID:12819032 |
RGD:1580850 |
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
severity |
IMP |
|
RGD |
PMID:12709397 |
RGD:7244143 |
NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826
|
|
G |
Suz12 |
SUZ12 polycomb repressive complex 2 subunit |
|
IEP |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr11:79,883,932...79,924,949
Ensembl chr11:79,883,932...79,924,949
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
ISO |
|
RGD |
PMID:11796005 |
RGD:11062062 |
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
|
|
G |
Tlr2 |
toll-like receptor 2 |
treatment severity |
ISO IEP IMP IDA |
|
RGD |
PMID:23239000 PMID:11801667 PMID:20130923 PMID:22750071 PMID:23023072 |
RGD:7207892, RGD:7241087, RGD:7240552, RGD:7207896, RGD:7207894 |
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
|
|
G |
Tlr4 |
toll-like receptor 4 |
treatment |
ISO IEP IMP |
|
RGD |
PMID:23239000 PMID:11801667 PMID:20130923 |
RGD:7207892, RGD:7241087, RGD:7240552 |
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:19925291 |
RGD:2315112 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:22728466 |
RGD:7245543 |
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:20164827 |
RGD:7240507 |
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
|
|
G |
Vwf |
Von Willebrand factor |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:12684225 |
RGD:11080744 |
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
|
|
G |
Wt1 |
WT1 transcription factor |
|
IEP |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr 2:104,956,874...105,003,959
Ensembl chr 2:104,956,874...105,003,961
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
ISO |
associated with Diabetes Mellitus, Type 2 |
RGD |
PMID:22995295 PMID:20616412 |
RGD:7247637, RGD:7247695 |
NCBI chr17:74,190,890...74,257,369
Ensembl chr17:74,190,890...74,257,191
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
ISO |
|
RGD |
PMID:23762489 |
RGD:8695935 |
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
|
|
G |
Adm |
adrenomedullin |
treatment |
ISO |
mRNA,protein:increased expression:liver,plasma: |
RGD |
PMID:19212187 PMID:19212187 |
RGD:7364958, RGD:7364958 |
NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:21431875 |
RGD:10402078 |
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
treatment |
IMP ISO |
protein:altered expression:liver (mouse) protein:altered expression:liver (rat) |
RGD |
PMID:30671488 PMID:29589772 |
RGD:15036807, RGD:14975297 |
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
|
|
G |
Bad |
BCL2-associated agonist of cell death |
treatment |
ISO |
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22647552 PMID:22847887 |
RGD:10053673, RGD:10053710 |
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
|
|
G |
Bax |
BCL2-associated X protein |
treatment |
ISO |
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22647552 PMID:21092002 PMID:22847887 |
RGD:10053673, RGD:5134995, RGD:10053710 |
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
treatment |
ISO |
associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22847887 PMID:21092002 |
RGD:10053710, RGD:5134995 |
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
treatment |
ISO |
associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22847887 |
RGD:10053710 |
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
C3 |
complement component 3 |
treatment |
ISO |
|
RGD |
PMID:19854450 |
RGD:11040888 |
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
Casp12 |
caspase 12 |
treatment |
ISO |
|
RGD |
PMID:29428101 |
RGD:13782166 |
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
|
|
G |
Casp8 |
caspase 8 |
treatment |
ISO IMP |
|
RGD |
PMID:23423194 PMID:15300206 |
RGD:8661760, RGD:14695087 |
NCBI chr 1:58,834,398...58,886,662
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:23364428 |
RGD:13782358 |
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
treatment severity |
ISO IMP |
mRNA, protein:increased expression:liver, serum (rat) |
RGD |
PMID:9500701 PMID:10630515 PMID:27229110 |
RGD:8549627, RGD:14995929, RGD:14995460 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
treatment severity |
IMP IDA |
|
RGD |
PMID:28623253 PMID:28623253 |
RGD:14995305, RGD:14995305 |
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
severity |
IMP |
|
RGD |
PMID:27229110 |
RGD:14995460 |
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
|
|
G |
Cd14 |
CD14 antigen |
|
ISO |
|
RGD |
PMID:22564590 |
RGD:7183676 |
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
|
|
G |
Cd40 |
CD40 antigen |
treatment |
ISO |
|
RGD |
PMID:14741776 |
RGD:8547795 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cfh |
complement component factor h |
treatment |
ISO |
mRNA,protein:decreased expression:liver,plasma: |
RGD |
PMID:19212187 PMID:19212187 |
RGD:7364958, RGD:7364958 |
NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
|
|
G |
Cs |
citrate synthase |
|
ISO |
|
RGD |
PMID:25416448 |
RGD:13504849 |
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
|
|
G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
treatment |
ISO |
|
RGD |
PMID:21092002 PMID:21092002 |
RGD:5134995, RGD:5134995 |
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
treatment |
IMP |
|
RGD |
PMID:18041715 |
RGD:27095942 |
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Elane |
elastase, neutrophil expressed |
|
ISO |
|
RGD |
PMID:10588515 |
RGD:10450560 |
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:25769561 |
RGD:15090809 |
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
|
|
G |
Epor |
erythropoietin receptor |
|
ISO |
protein:increased phosphorylation:liver: |
RGD |
PMID:25769561 |
RGD:15090809 |
NCBI chr 9:21,870,193...21,874,915
Ensembl chr 9:21,870,193...21,874,802
|
|
G |
F3 |
coagulation factor III |
treatment |
ISO |
|
RGD |
PMID:11750579 |
RGD:11341708 |
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
|
|
G |
Fadd |
Fas (TNFRSF6)-associated via death domain |
treatment |
ISO |
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chr 7:144,132,060...144,136,178
Ensembl chr 7:144,131,055...144,136,200
|
|
G |
Fas |
Fas (TNF receptor superfamily member 6) |
treatment |
ISO |
protein:increased expression:liver |
RGD |
PMID:17235585 PMID:18561025 PMID:16222447 |
RGD:2290283, RGD:14700680, RGD:1600351 |
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
treatment |
ISO |
|
RGD |
PMID:18561025 |
RGD:14700680 |
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:23503399 |
RGD:9685021 |
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
|
RGD |
PMID:12651615 |
RGD:7205470 |
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
ISO |
associated with nonalcoholic fatty liver disease |
RGD |
PMID:28807209 |
RGD:13792730 |
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
|
|
G |
Gstm1 |
glutathione S-transferase, mu 1 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
|
|
G |
H2ax |
H2A.X variant histone |
treatment |
ISO |
|
RGD |
PMID:23792534 |
RGD:8693718 |
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
protein:increased oxidation:liver mRNA, protein:increased expression, altered localization:serum, hepatocyte, cytoplasm |
RGD |
PMID:24578610 PMID:22514737 PMID:21431875 |
RGD:10402068, RGD:10402175, RGD:10402078 |
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:20446775 |
RGD:10755725 |
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hp |
haptoglobin |
treatment |
ISO |
|
RGD |
PMID:17187421 PMID:21699906 |
RGD:1626366, RGD:11041815 |
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
associated with Intestinal Reperfusion Injury;protein:increased expression:liver |
RGD |
PMID:7884306 PMID:8780571 |
RGD:11520784, RGD:14402044 |
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
severity |
IMP |
|
RGD |
PMID:28938192 |
RGD:14985248 |
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
|
|
G |
Ikbkg |
inhibitor of kappaB kinase gamma |
treatment |
ISO |
|
RGD |
PMID:22381173 |
RGD:12791280 |
NCBI chr X:73,436,883...73,498,013
Ensembl chr X:73,436,896...73,497,460
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:21911118 |
RGD:7364839 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il18 |
interleukin 18 |
treatment |
ISO IMP |
|
RGD |
PMID:25919765 PMID:14999688 |
RGD:14696667, RGD:14696668 |
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il18bp |
interleukin 18 binding protein |
|
ISO |
mRNA,protein:increased expression:liver |
RGD |
PMID:25919765 |
RGD:14696667 |
NCBI chr 7:101,664,281...101,669,699
Ensembl chr 7:101,664,092...101,667,897
|
|
G |
Il1a |
interleukin 1 alpha |
treatment |
ISO |
mRNA:increased expression:lung protein:increased expression:serum |
RGD |
PMID:19595018 PMID:9840148 PMID:19283466 |
RGD:2314952, RGD:11059517, RGD:6907377 |
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
ISO IEP |
associated with Cholestasis |
RGD |
PMID:21468628 PMID:32155285 |
RGD:7175318, RGD:155260323 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO |
rat model treated with human protein |
RGD |
PMID:9000676 PMID:12451245 |
RGD:6909138, RGD:8551710 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Il6 |
interleukin 6 |
treatment |
ISO IEP |
|
RGD |
PMID:24752458 PMID:32155285 |
RGD:11062134, RGD:155260323 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
ISO |
|
RGD |
PMID:22288937 |
RGD:10403073 |
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:12134092 |
RGD:9685192 |
NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
|
|
G |
Map3k7 |
mitogen-activated protein kinase kinase kinase 7 |
ameliorates exacerbates |
IMP IEP |
protein:increased phosphorylation:liver (mouse) |
RGD |
PMID:30076625 PMID:30622220 |
RGD:155804280, RGD:155882441 |
NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
protein:increased activity:liver: |
RGD |
PMID:11679968 |
RGD:10412680 |
NCBI chr14:33,099,855...33,169,215
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mfn2 |
mitofusin 2 |
treatment |
ISO |
mRNA, protein:decreased expression:liver (rat) |
RGD |
PMID:27363631 PMID:24898700 |
RGD:12910833, RGD:13204829 |
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
|
|
G |
Mir145a |
microRNA 145a |
|
ISO |
mRNA:decreased expression:small intestine (rat) |
RGD |
PMID:23166305 |
RGD:155230822 |
NCBI chr18:61,780,896...61,780,965
Ensembl chr18:61,780,896...61,780,965
|
|
G |
Mir155 |
microRNA 155 |
|
IMP |
|
RGD |
PMID:28640790 |
RGD:21079442 |
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
|
|
G |
Mir210 |
microRNA 210 |
treatment |
IEP |
|
RGD |
PMID:32155285 |
RGD:155260323 |
NCBI chr 7:140,801,297...140,801,406
Ensembl chr 7:140,801,297...140,801,406
|
|
G |
Mir21a |
microRNA 21a |
|
ISO |
RNA:increased expression:liver |
RGD |
PMID:29187695 |
RGD:41410824 |
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
|
|
G |
Mir223 |
microRNA 223 |
|
IEP |
RNA:increased expression:liver RNA:increased expression:serum,liver |
RGD |
PMID:19104939 PMID:28646120 |
RGD:13831297, RGD:21408574 |
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
|
|
G |
Mir34a |
microRNA 34a |
|
ISO |
miRNA:increased expression:liver |
RGD |
PMID:28963950 |
RGD:14695005 |
NCBI chr 4:150,152,911...150,153,012
Ensembl chr 4:150,152,911...150,153,012
|
|
G |
Mmp15 |
matrix metallopeptidase 15 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 8:96,078,924...96,100,921
Ensembl chr 8:96,078,896...96,101,708
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
ISO |
associated with Fatty Liver;mRNA, protein:decreased expression, decreased activity:liver |
RGD |
PMID:17255325 |
RGD:8547976 |
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Muc1 |
mucin 1, transmembrane |
|
ISO |
mRNA, protein:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
|
|
G |
Muc17 |
mucin 17, cell surface associated |
|
ISO |
mRNA, protein:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chr 5:137,163,772...137,202,809
Ensembl chr 5:137,163,770...137,202,830
|
|
G |
Muc4 |
mucin 4 |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chr16:32,555,089...32,602,761
Ensembl chr16:32,555,015...32,602,754
|
|
G |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
|
IEP |
mRNA,protein:increased expression:liver: |
RGD |
PMID:36092961 |
RGD:268357360 |
NCBI chr18:80,649,418...80,756,286
Ensembl chr18:80,649,420...80,756,286
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
treatment |
ISO |
|
RGD |
PMID:22288937 PMID:31952110 |
RGD:10403073, RGD:21201304 |
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
treatment |
ISO |
|
RGD |
PMID:28966130 |
RGD:13450941 |
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Proc |
protein C |
treatment |
ISO |
|
RGD |
PMID:12605111 PMID:18507760 |
RGD:11100021, RGD:11100046 |
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
|
|
G |
Serpinc1 |
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
treatment |
ISO |
|
RGD |
PMID:24726586 PMID:8589354 |
RGD:10450597, RGD:11038771 |
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
|
ISO |
protein:increased activity:plasma (rat) |
RGD |
PMID:12353078 |
RGD:8547901 |
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Serping1 |
serine (or cysteine) peptidase inhibitor, clade G, member 1 |
treatment |
ISO |
|
RGD |
PMID:16367929 |
RGD:1580273 |
NCBI chr 2:84,595,704...84,605,778
Ensembl chr 2:84,595,731...84,605,788
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
ISO |
|
RGD |
PMID:24557422 |
RGD:9497542 |
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
|
ISO |
|
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
treatment |
ISO |
human gene in a rat model |
RGD |
PMID:16555330 PMID:11779401 |
RGD:8655889, RGD:1581095 |
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Sod3 |
superoxide dismutase 3, extracellular |
treatment |
ISO |
human gene in a rat model |
RGD |
PMID:11779401 |
RGD:1581095 |
NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
|
|
G |
Tert |
telomerase reverse transcriptase |
treatment |
ISO |
|
RGD |
PMID:19545665 |
RGD:11038676 |
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
ISO |
|
RGD |
PMID:9921794 |
RGD:11062061 |
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
|
|
G |
Tlr2 |
toll-like receptor 2 |
treatment |
IEP ISO |
|
RGD |
PMID:16038046 PMID:25769561 |
RGD:15090805, RGD:15090809 |
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
|
|
G |
Tlr4 |
toll-like receptor 4 |
treatment severity |
ISO IEP IMP |
mRNA:increased expression:liver protein:increased expression:membrane raft: |
RGD |
PMID:21431875 PMID:21693218 PMID:22797797 PMID:23395256 PMID:27064547 |
RGD:10402078, RGD:5685379, RGD:14697702, RGD:14697699, RGD:14697698 |
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO IEP |
protein:increased expression:serum (rat) |
RGD |
PMID:24726586 PMID:32155285 PMID:11592783 PMID:19357028 PMID:11129814 PMID:21125813 PMID:10454827 PMID:15457564 PMID:17164725 More...
|
RGD:10450597, RGD:155260323, RGD:2325259, RGD:15039406, RGD:14995473, RGD:14995447, RGD:14985258, RGD:14985257, RGD:14696803 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
ISO |
protein:increased localization:mitochondrion |
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
G |
Tradd |
TNFRSF1A-associated via death domain |
treatment |
ISO |
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chr 8:105,985,207...105,991,226
Ensembl chr 8:105,984,918...105,991,241
|
|
G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:22195248 |
RGD:7175309 |
NCBI chr 7:100,142,565...100,148,832
Ensembl chr 7:100,142,544...100,151,227
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
|
RGD |
PMID:26451003 |
RGD:15036791 |
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
ISO |
|
RGD |
PMID:24768926 |
RGD:13209011 |
NCBI chr17:74,190,890...74,257,369
Ensembl chr17:74,190,890...74,257,191
|
|
|
G |
Bax |
BCL2-associated X protein |
treatment ameliorates |
ISO IEP |
|
RGD |
PMID:23953793 PMID:34238924 |
RGD:10054119, RGD:153350155 |
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
treatment |
ISO |
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Col1a1 |
collagen, type I, alpha 1 |
|
IEP |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
|
|
G |
Col3a1 |
collagen, type III, alpha 1 |
|
IEP |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
|
|
G |
Crebbp |
CREB binding protein |
ameliorates |
IMP |
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861
|
|
G |
Egr1 |
early growth response 1 |
treatment |
ISO |
|
RGD |
PMID:22878149 PMID:23232597 |
RGD:10395282, RGD:10395299 |
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
|
|
G |
Elane |
elastase, neutrophil expressed |
treatment |
ISO |
|
RGD |
PMID:17888675 |
RGD:10450582 |
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
mRNA:increased expression:lung (rat) |
RGD |
PMID:35600952 |
RGD:155663563 |
NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:22115333 |
RGD:10402095 |
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:21227458 |
RGD:10755577 |
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:22503847 |
RGD:7240537 |
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Il1b |
interleukin 1 beta |
ameliorates |
ISO IEP |
protein:increased expression:lung (rat) |
RGD |
PMID:23142117 PMID:34238924 PMID:23122581 |
RGD:7183185, RGD:153350155, RGD:7204125 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il4 |
interleukin 4 |
treatment |
ISO |
|
RGD |
PMID:24365768 |
RGD:10402797 |
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Il6 |
interleukin 6 |
ameliorates |
IEP |
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Kras |
Kirsten rat sarcoma viral oncogene homolog |
ameliorates |
IEP |
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased activity:lung |
RGD |
PMID:18694576 |
RGD:5129703 |
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Myc |
myelocytomatosis oncogene |
treatment |
ISO |
|
RGD |
PMID:22503847 |
RGD:7240537 |
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
ISO IEP |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:20815765 PMID:25382268 |
RGD:4892012, RGD:11533932 |
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
treatment |
ISO |
|
RGD |
PMID:21781312 |
RGD:6771212 |
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
ISO |
protein:increased expression:alveolar macrophage (rat) |
RGD |
PMID:21781312 PMID:16449942 |
RGD:6771212, RGD:11541083 |
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
|
|
G |
Proc |
protein C |
treatment |
ISO |
|
RGD |
PMID:19782612 |
RGD:11100035 |
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
treatment |
ISO |
|
RGD |
PMID:11606484 |
RGD:11080966 |
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Tlr4 |
toll-like receptor 4 |
treatment |
ISO |
|
RGD |
PMID:22115333 |
RGD:10402095 |
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tnf |
tumor necrosis factor |
ameliorates |
ISO IEP |
|
RGD |
PMID:17294835 PMID:34238924 |
RGD:4143397, RGD:153350155 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Zfp36 |
zinc finger protein 36 |
exacerbates |
IMP |
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr 7:28,076,208...28,078,680
Ensembl chr 7:28,076,209...28,079,678
|
|
|
G |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
|
IAGP |
|
RGD |
PMID:18316485 |
RGD:2301903 |
NCBI chr 7:45,753,952...45,829,441
Ensembl chr 7:45,753,947...45,829,457
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
protein:increased expression |
RGD |
PMID:16641873 |
RGD:1624305 |
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16155579 |
|
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
|
|
G |
Adrb1 |
adrenergic receptor, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10900253 PMID:17201736 |
RGD:5129149 |
NCBI chr19:56,710,549...56,713,582
Ensembl chr19:56,710,631...56,721,545
|
|
G |
Adrb2 |
adrenergic receptor, beta 2 |
|
ISO |
|
RGD |
PMID:16269402 |
RGD:1598746 |
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
protein:increased expression:heart (rat) |
RGD |
PMID:16505177 |
RGD:1625342 |
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
|
|
G |
Agl |
amylo-1,6-glucosidase, 4-alpha-glucanotransferase |
|
ISO |
|
RGD |
PMID:9281456 |
RGD:1598779 |
NCBI chr 3:116,533,648...116,601,815
Ensembl chr 3:116,533,648...116,601,815
|
|
G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:2535056 PMID:19166939 |
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
ISO |
protein:increased expression:myocardium |
RGD |
PMID:21078800 |
RGD:5129194 |
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
|
|
G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
ISO IMP |
protein:decreased expression:mitochondrion: |
RGD |
PMID:23685150 PMID:23685150 |
RGD:10053560, RGD:10053560 |
NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
ISO |
protein:increased phosphorylation:heart left ventricle |
RGD |
PMID:20217242 |
RGD:5509104 |
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Akt2 |
thymoma viral proto-oncogene 2 |
|
ISO |
|
RGD |
PMID:16418318 |
RGD:2313347 |
NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9572063 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
ISO |
|
RGD |
PMID:23468836 |
RGD:7241598 |
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:20011686 |
RGD:2317527 |
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
|
|
G |
Angpt2 |
angiopoietin 2 |
|
ISO |
mRNA, protein:increased expression:myocardium (rat) |
RGD |
PMID:12737621 |
RGD:1601505 |
NCBI chr 8:18,740,279...18,791,578
Ensembl chr 8:18,740,279...18,791,578
|
|
G |
Ank1 |
ankyrin 1, erythroid |
|
ISO |
|
RGD |
PMID:9378703 |
RGD:1599110 |
NCBI chr 8:23,464,852...23,640,517
Ensembl chr 8:23,464,860...23,640,513
|
|
G |
Ank2 |
ankyrin 2, brain |
|
ISO |
|
RGD |
PMID:9378703 |
RGD:1599110 |
NCBI chr 3:126,715,256...127,293,996
Ensembl chr 3:126,715,261...127,292,999
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
|
ISO |
protein:decreased expression:myocardium |
RGD |
PMID:19299913 |
RGD:5133278 |
NCBI chr19:36,089,365...36,097,244
Ensembl chr19:36,089,361...36,097,499
|
|
G |
Anxa1 |
annexin A1 |
treatment |
ISO IMP |
protein:increased expression:heart, leukocyte |
RGD |
PMID:11641252 PMID:22924634 PMID:22924634 |
RGD:2306910, RGD:7421655, RGD:7421655 |
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
|
|
G |
Apex1 |
apurinic/apyrimidinic endonuclease 1 |
|
ISO |
protein:altered localization:cytoplasm |
RGD |
PMID:17602955 |
RGD:2315672 |
NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596
|
|
G |
Arrb2 |
arrestin, beta 2 |
|
ISO |
|
RGD |
PMID:29016703 |
RGD:13506827 |
NCBI chr11:70,323,051...70,331,654
Ensembl chr11:70,323,461...70,331,654
|
|
G |
Atf3 |
activating transcription factor 3 |
|
ISO |
|
RGD |
PMID:11485922 |
RGD:7327201 |
NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
|
|
G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29702141 |
|
NCBI chr 3:101,483,535...101,512,023
Ensembl chr 3:101,483,535...101,512,000
|
|
G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
|
ISO |
|
RGD |
PMID:17630344 |
RGD:13782075 |
NCBI chr 7:126,045,032...126,062,245
Ensembl chr 7:126,045,030...126,062,280
|
|
G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10734148 PMID:28637456 |
RGD:13782080 |
NCBI chr 5:122,591,576...122,640,288
Ensembl chr 5:122,591,576...122,640,288
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
treatment |
ISO |
protein:decreased expression:myocardium (rat) |
RGD |
PMID:26109848 PMID:25305180 |
RGD:13792666, RGD:13792676 |
NCBI chr10:79,974,451...79,981,662
Ensembl chr10:79,974,466...79,981,652
|
|
G |
Bad |
BCL2-associated agonist of cell death |
treatment |
ISO |
protein:increased expression, decreased serine phosphorylation:heart |
RGD |
PMID:15339931 PMID:23364609 |
RGD:2292700, RGD:10053674 |
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
|
|
G |
Bax |
BCL2-associated X protein |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20026869 PMID:21223820 PMID:31583047 PMID:25547710 |
RGD:10054103, RGD:155230831, RGD:13782178 |
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
treatment |
ISO |
|
RGD |
PMID:16289365 PMID:31583047 PMID:20821058 PMID:23364609 |
RGD:1599484, RGD:155230831, RGD:11561911, RGD:10053674 |
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
treatment |
ISO |
|
RGD |
PMID:12668130 |
RGD:11035287 |
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Becn1 |
beclin 1, autophagy related |
treatment |
ISO IMP |
|
RGD |
PMID:20821058 PMID:20812860 |
RGD:11561911, RGD:11561944 |
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
ISO |
protein:increased cleavage:heart: |
RGD |
PMID:19940077 PMID:11934844 |
RGD:2317561, RGD:13782263 |
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
|
|
G |
Blk |
B lymphoid kinase |
|
ISO |
mRNA:increased expression:left ventricle (rat) |
RGD |
PMID:17562528 |
RGD:1642307 |
NCBI chr14:63,610,286...63,654,636
Ensembl chr14:63,610,285...63,654,486
|
|
G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
treatment |
ISO |
protein:decreased expression:myocardium (human) |
RGD |
PMID:16645637 PMID:28661226 |
RGD:11561983, RGD:155260328 |
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
|
|
G |
Brd4 |
bromodomain containing 4 |
|
IEP |
mRNA,protein:increased expression:heart |
RGD |
PMID:33982231 |
RGD:155883171 |
NCBI chr17:32,415,246...32,503,717
Ensembl chr17:32,415,248...32,503,696
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
|
ISO |
mRNA:increased expression:heart |
RGD |
PMID:12909328 |
RGD:2289075 |
NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
|
|
G |
C3 |
complement component 3 |
|
ISO |
protein:increased expression:myocardium |
RGD |
PMID:11560858 |
RGD:1582136 |
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
Casp1 |
caspase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14998631 |
|
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Casp12 |
caspase 12 |
treatment |
ISO |
protein:increased activity:myocardium CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:14998631 PMID:19406177 PMID:25547710 |
RGD:2311458, RGD:13782178 |
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
|
|
G |
Casp3 |
caspase 3 |
ameliorates treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:14998631 PMID:18470603 PMID:30259997 PMID:29538428 |
RGD:2293314, RGD:329337366, RGD:13782276 |
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp7 |
caspase 7 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:14998631 PMID:29538428 |
RGD:13782276 |
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte |
CTD RGD |
PMID:14998631 PMID:11934844 |
RGD:13782263 |
NCBI chr 1:58,834,398...58,886,662
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
ameliorates treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte,endothelial cell |
CTD RGD |
PMID:14998631 PMID:30259997 PMID:29538428 PMID:11934844 |
RGD:329337366, RGD:13782276, RGD:13782263 |
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Casr |
calcium-sensing receptor |
|
ISO |
protein:increased expression:ventricular myocardium (rat) |
RGD |
PMID:21766206 |
RGD:7205698 |
NCBI chr16:36,310,947...36,382,605
Ensembl chr16:36,314,058...36,382,503
|
|
G |
Cast |
calpastatin |
|
ISO |
|
RGD |
PMID:12482022 |
RGD:5683872 |
NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:21600015 PMID:11510883 |
RGD:1581149 |
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Cbl |
Casitas B-lineage lymphoma |
severity |
IMP |
|
RGD |
PMID:24583314 |
RGD:11251947 |
NCBI chr 9:44,054,273...44,145,556
Ensembl chr 9:44,054,273...44,145,346
|
|
G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
ISO |
mRNA:increased expression:heart (rat) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12087064 PMID:10908159 |
RGD:8549625 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
ISO |
protein:decreased expression:monocyte: |
RGD |
PMID:15786508 |
RGD:4892017 |
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
|
|
G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
treatment |
ISO |
protein:decreased expression:blood, monocyte (human) |
RGD |
PMID:15786508 PMID:23456481 |
RGD:4892017, RGD:8552227 |
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:18466417 |
RGD:11341714 |
NCBI chr 1:58,750,353...58,798,043
Ensembl chr 1:58,750,667...58,798,043
|
|
G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
ISO |
|
RGD |
PMID:18771032 |
RGD:2316217 |
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
|
|
G |
Cnr2 |
cannabinoid receptor 2 (macrophage) |
|
ISO |
|
RGD |
PMID:17950273 |
RGD:2316224 |
NCBI chr 4:135,622,500...135,647,530
Ensembl chr 4:135,622,705...135,647,518
|
|
G |
Cobll1 |
Cobl-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34355838 |
|
NCBI chr 2:64,918,683...65,069,742
Ensembl chr 2:64,918,683...65,069,747
|
|
G |
Crebbp |
CREB binding protein |
treatment |
ISO |
|
RGD |
PMID:24338162 |
RGD:153352322 |
NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21122204 |
RGD:5128547 |
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
|
|
G |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
|
ISO |
protein:decreased expression:blood, monocyte |
RGD |
PMID:15786508 |
RGD:4892017 |
NCBI chr 9:119,877,749...119,897,362
Ensembl chr 9:119,730,682...119,898,945
|
|
G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
ISO |
|
RGD |
PMID:11342480 |
RGD:5135269 |
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
ISO |
|
RGD |
PMID:11342480 |
RGD:5135269 |
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
ISO |
|
RGD |
PMID:11342480 |
RGD:5135269 |
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
|
|
G |
Cybb |
cyt | |